US20090177127A1 - Chest Compression Device with Electro-Stimulation - Google Patents

Chest Compression Device with Electro-Stimulation Download PDF

Info

Publication number
US20090177127A1
US20090177127A1 US12/392,018 US39201809A US2009177127A1 US 20090177127 A1 US20090177127 A1 US 20090177127A1 US 39201809 A US39201809 A US 39201809A US 2009177127 A1 US2009177127 A1 US 2009177127A1
Authority
US
United States
Prior art keywords
electro
compression
chest
stimulation
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/392,018
Inventor
Darren R. Sherman
Steven R. Bystrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoll Circulation Inc
Original Assignee
Zoll Circulation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoll Circulation Inc filed Critical Zoll Circulation Inc
Priority to US12/392,018 priority Critical patent/US20090177127A1/en
Assigned to EMERGENCY MEDICAL SYSTEMS, INC. reassignment EMERGENCY MEDICAL SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BYSTROM, STEVEN R., SHERMAN, DARREN R.
Assigned to REVIVANT CORPORATION reassignment REVIVANT CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: EMERGENCY MEDICAL SYSTEMS, INC.
Assigned to ZOLL CIRCULATION, INC. reassignment ZOLL CIRCULATION, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: REVIVANT CORPORATION
Publication of US20090177127A1 publication Critical patent/US20090177127A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H31/00Artificial respiration or heart stimulation, e.g. heart massage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H31/00Artificial respiration or heart stimulation, e.g. heart massage
    • A61H31/004Heart stimulation
    • A61H31/005Heart stimulation with feedback for the user
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H31/00Artificial respiration or heart stimulation, e.g. heart massage
    • A61H31/004Heart stimulation
    • A61H31/006Power driven
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3601Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3904External heart defibrillators [EHD]
    • A61N1/39044External heart defibrillators [EHD] in combination with cardiopulmonary resuscitation [CPR] therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H31/00Artificial respiration or heart stimulation, e.g. heart massage
    • A61H2031/003Artificial respiration or heart stimulation, e.g. heart massage with alternated thorax decompression due to lateral compression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/01Constructive details
    • A61H2201/0173Means for preventing injuries
    • A61H2201/018By limiting the applied torque or force
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • A61H2201/5007Control means thereof computer controlled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • A61H2201/5023Interfaces to the user
    • A61H2201/5043Displays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • A61H2201/5023Interfaces to the user
    • A61H2201/5048Audio interfaces, e.g. voice or music controlled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • A61H2201/5097Control means thereof wireless
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/08Trunk
    • A61H2205/083Abdomen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00Measuring physical parameters of the user
    • A61H2230/04Heartbeat characteristics, e.g. E.G.C., blood pressure modulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00Measuring physical parameters of the user
    • A61H2230/20Blood composition characteristics
    • A61H2230/207Blood composition characteristics partial O2-value
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S601/00Surgery: kinesitherapy
    • Y10S601/06Artificial respiration conforming to shape of torso
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S601/00Surgery: kinesitherapy
    • Y10S601/08Artificial respiration with computer control
    • Y10S601/09Artificial respiration with computer control including biological sensors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S601/00Surgery: kinesitherapy
    • Y10S601/10Artificial respiration combined with non-artificial respiration therapy

Definitions

  • This invention relates to the resuscitation of cardiac arrest victims.
  • Cardiopulmonary resuscitation is a well known and valuable method of first aid.
  • CPR is used to resuscitate people who have suffered from cardiac arrest after heart attack, electric shock, chest injury and many other causes.
  • the heart stops pumping blood, and a person suffering cardiac arrest will soon suffer brain damage from lack of blood supply to the brain.
  • CPR requires repetitive chest compression to squeeze the heart and the thoracic cavity to pump blood through the body.
  • the victim is not breathing, and mouth to mouth artificial respiration or a bag valve mask is used to supply air to the lungs while the chest compression pumps blood through the body.
  • the methods of providing oxygenated airflow to the lungs are referred to as ventilation.
  • CPR and chest compression can save cardiac arrest victims, especially when applied immediately after cardiac arrest. Chest compression requires that the person providing chest compression repetitively push down on the sternum of the victim at 80-100 compressions per minute. CPR and closed chest compression can be used anywhere, wherever the cardiac arrest victim is stricken. In the field, away from the hospital, CPR may be accomplished by ill-trained by-standers or highly trained paramedics and ambulance personnel.
  • Barkalow Cardiopulmonary resuscitator Massager Pad
  • U.S. Pat. No. 4,570,615 the commercially available Thumper device, and other such devices, provide continuous automatic closed chest compression.
  • Barkalow and others provide a piston which is placed over the chest cavity and supported by an arrangement of beams.
  • the piston is placed over the sternum of a patient and set to repeatedly push downward on the chest under pneumatic power.
  • the victim must first be installed into the device, and the height and stroke length of the piston must be adjusted for the patient before use, leading to delay in chest compression.
  • Other analogous devices provide for hand operated piston action on the sternum.
  • Everette External Cardiac Compression Device, U.S. Pat. No.
  • the Kelly devices comprises a base which is placed over a central region of the chest, a belt which is wrapped around the patients chest and fastened at its opposite ends to the base, and a force converter connected to the base and the belt, and a manual actuator, so that the force converter converts the downward force on the manual actuators into chest compressing resultants directed toward the chest and directed tangentially to the chest.
  • Kelly illustrates installation of defibrillation electrodes on the wide band, he does not suggest integrating use of the electrodes with use of the compression belt in any manner.
  • a vest or belt designed for placement around the chest is provided with pneumatic bladders which are filled to exert compressive forces on the chest.
  • Scarberry Apparatus for Application of Pressure to a Human Body
  • U.S. Pat. No. 5,222,478 Jun. 29, 1993
  • Halperin Cardiopulmonary Resuscitation and Assisted Circulation System
  • U.S. Pat. No. 4,928,674 show examples of such devices.
  • Halperin for example, uses a vest fitted with air bladders that are repeatedly inflated to compress the chest. The bladders are deflated by application of a vacuum. Cyclic inflation and deflation of the vest is accomplished with a complicated arrangement of two-way and three-way valves, connected to the bladders within the vest with large bore hoses.
  • Our own CPR devices use a compression belt around the chest of the patient which is repetitively tightened and relaxed through the action of a belt tightening spool powered by an electric motor.
  • the motor is controlled by control system which times the compression cycles, limits the torque applied by the system (thereby limiting the power of the compression applied to the victim), provides for adjustment of the torque limit based on biological feedback from the patient, provides for respiration pauses, and controls the compression pattern through an assembly of clutches and/or brakes connecting the motor to the belt spool.
  • Our devices have achieved high levels of blood flow in animal studies.
  • Abdominal binding is a technique used to enhance the effectiveness of the CPR chest compression. Abdominal binding is achieved by binding the stomach during chest compression to limit the waste of compressive force which is lost to deformation of the abdominal cavity caused by the compression of the chest. It also inhibits flow of blood into the lower extremities (and promotes bloodflow to the brain).
  • Alferness, Manually-Actuable CPR apparatus, U.S. Pat. No. 4,349,015 (Sep. 14, 1982) provides for abdominal restraint during the compression cycle with a bladder that is filled during compression. Counterpulsion is a method in which slight pressure is applied to the abdomen in between each chest compression.
  • a manual device for counterpulsion is shown in Shock, et al., Active Compression/Decompression Device for Cardiopulmonary Resuscitation, U.S. Pat. No. 5,630,789 (May 20, 1997).
  • This device is like a seesaw mounted over the chest with a contact cup on each end of the seesaw.
  • One end of the seesaw is mounted over the chest, and the other end is mounted over the abdomen, and the device is operated by rocking back and forth, alternately applying downward force on each end.
  • Electroventilation is the process of ventilating a patient by electrically stimulating the nerves that control the muscles used for respiration. It is proposed for use in patients that have been paralyzed such that the normal motor impulses transmitted to the diaphragm are not transmitted.
  • Geddes, Demand Electroventilator, U.S. Pat. No. 4,827,935 (May 9, 1989) illustrates the operation of an electroventilator. He illustrates placement of two electrodes on the chest (one on either side), and application of electrical stimulus through the electrodes to stimulate the nerves responsible for triggering the muscles used in respiration.
  • Geddes system provided for smooth inspiration, which was an improvement over the sharp gasping action caused by earlier electroventilation systems.
  • the nerves identified by Geddes are the phrenic nerve, which controls the diaphragm, and the intercostal nerves which control the intercostal muscles (muscles between the ribs).
  • a set of electrodes is provided on the neck and/or chest of the patient for electrically stimulating the diaphragm to provide an inhalation, thereby ventilating the patient, and a control system provides for coordination of the ventilating stimulus with the compression system so that ventilation is initiated during ventilation pauses in the compression pattern (these compression pauses would normally be used for mouth-to-mouth or bag ventilation).
  • a set of electrodes is provided for installation over the patient's abdomen, to cause contraction of the abdominal muscles, and a control system provides for coordination of the abdominal muscle stimulation and the chest compression mechanism in order to effect abdominal binding or counterpulsion.
  • a set of electrodes is provided for defibrillating the patient, and a control system is provided for coordinating the initiating the defibrillation shock in sync with the chest compression mechanism.
  • the defibrillation electrodes may be used for pacing the heart. Additional electrodes may be supplied for control of the glottic opening.
  • An overall control system is provided for coordinating the action of the chest compression device with the operation of various electrical stimulus devices to enhance the effectiveness of the resuscitation regimen.
  • FIG. 1 is diagram of a typical chest compression device.
  • FIG. 2 is diagram of a typical patient illustrating the electrode placement.
  • FIG. 3 is a block diagram of the motor control system for use for basic CPR chest compression.
  • FIG. 4A is a block diagram of the motor control system for use in electro-ventilation during respiration pauses of the compression system, for use in electro-counterpulsion during operation of the compression system, and for use in the synchronized cardioverting shock system.
  • FIG. 4B is a continuation of FIG. 4A .
  • FIG. 1 shows the system mounted on a patient 1 and ready for use.
  • the chest compression subsystem 2 comprises the motor box 3 , the belt cartridge 4 , and the compression belt 5 with left and right portions 5 L and 5 R.
  • the belt is fastened around the patient with fasteners 6 , which may be buckles, Velcro® hook and loop fasteners or other fasteners with sensors to sense when the belt is fastened.
  • Ventilation electrodes 7 L and 7 R are mounted on the belts in the area of the lower chest, over the diaphragm, placed bilaterally.
  • Bipolar electrodes 8 L and 8 R may also be placed on the neck, bilaterally, to stimulate the phrenic nerve which courses downwardly through the neck.
  • Defibrillation electrodes 9 R and 9 L are placed in the right sternum parasaggital location 10 and left rib medial location 11 , and they may also be located below the patient, on the spine between the shoulder blades, and on the center of the chest, respectively. These electrodes are also used for establishing the electrical contact needed for EKG sensing.
  • Counterpulsion electrodes 12 i and 12 s are placed on the skin over the abdominal or rectus muscles, with a line of positive electrodes placed in the superior position and a line of ground electrodes placed in the inferior position.
  • Glottic control electrodes are disposed on electrode patch 13 placed on the neck along the tracheo-esophageal groove.
  • FIG. 2 illustrates the nerves of the human body upon which the electro-stimulation system may act.
  • the phrenic nerves 14 L and 14 R are believed to be used by the body to control the diaphragm 15 .
  • the phrenic nerves course from the neck 16 , superficially over the scalene muscles, and deep within the chest around the heart to the diaphragm.
  • the phrenic nerves divide into the phrenicoabdominal branches 17 .
  • the phrenic nerves comprise both efferent and afferent nerves which run together along their common course.
  • the phrenic nerves and the diaphragm are principal components of breathing.
  • intercostal nerves located between the ribs 18 and controlling the external intercostal muscles, and the internal intercostal muscles.
  • the abdominal muscles 19 controlled by intercostal nerves, are used in active breathing.
  • the electrodes 7 L and 7 R, 8 L and 8 R, 9 L and 9 R, 12 i and 12 s , and 13 are illustrated in the appropriate positions as viewed from the front of the patient.
  • the airway is controlled by the glottic opening (including the vocal cords) which is controlled by the recurrent laryngeal nerve.
  • the operation of the glottis is not typically impaired in cardiac arrest patients. However, its operation can be influenced by electrical stimulation of the recurrent laryngeal nerves, and closure during the compression period of the CPR device enhances intrathoracic pressure.
  • the recurrent laryngeal nerve may be stimulated with electrical stimulation delivered most conveniently through an electrode mounted on the skin of the neck, along the tracheo-esophageal groove.
  • Stimulation of the RLN will open or close the glottic opening depending on the frequency of the applied electrical stimulus. For transcutaneous stimulation, stimulation at frequencies below 30 Hertz cause the vocal cord to open, while stimulation at frequencies from 40-100 Hertz will cause the vocal cords to close. Stimulation with pulses ranging up to 20 milli-amps and pulses of 0.5 msec to 2 msec duration should be effective to stimulate closure of the glottic opening.
  • the motor nerve (such as the phrenic nerve) is used by the body to transmit a nervous system impulse to activating nerves which directly innervate the muscles.
  • the motor nerves may be stimulated by an electrical pulse to cause the motor nerve to stimulate the activating nerves within the muscle to be contracted.
  • the activating nerves that directly innervate the muscles may be locally stimulated to cause muscle contraction.
  • the diaphragm, the intercostal muscles, and the abdominal muscles may be stimulated with both electrical mechanisms.
  • the CPR device illustrated in FIG. 1 stimulates the motor nerve and the activating nerves, either singly or together, to cause contraction of the diaphragm, the intercostal muscles, and the abdominal muscles.
  • the diaphragm and the intercostal muscles are stimulated in coordination with the compression mechanism to cause those muscles to cause an inhalation.
  • the abdominal muscles are stimulated in coordination with the compression mechanism to make those muscles contract.
  • the contraction of the abdominal muscles results in a binding of the abdomen that, when syncopated with chest compressions provides an electrically induced version of counterpulsion which increases the effectiveness of the chest compression mechanism in creating blood flow within a patient.
  • the manner in which electrical stimulation may be applied may vary considerably and yet still provide effective activation of the muscle groups involved.
  • the electrical stimulation is preferably applied in repeated bursts comprising a number of pulses.
  • the pulses are characterized by their pulse width and pulse amplitude (current or voltage).
  • the pulse bursts, or pulse trains may be characterized by the pulse train width and the number of pulse bursts per second.
  • the pulses employed may be monophasic, biphasic, or polyphasic, according to medical indications at the time of use.
  • the pulses may be DC pulses or AC pulses of varying frequency.
  • the respiratory stimulation is provided through the electrodes 8 L and 8 R on the neck or electrodes 7 L and 7 R over the general area of the diaphragm.
  • the electrical stimulation may be provided in single amplitude pulse trains containing numerous pulses of 0.03 msec pulse width, delivered at 60 pulses per second, delivered at amplitude up to one amp.
  • a linearly ramped pulse train with an initial amplitude of about 10-50 milli-amps and a final amplitude of about 100-200 milli-amps, with pulse widths of 0.01 to 0.1 msec, and 60 pulses per second, with pulse train of 0.5 to 2 seconds.
  • a frequency modulated pulse train may also be used, with a pulse train of about 1 second, individual pulses of 0.01 msec to 0.1 msec, an amplitude of 50-200 milli-amps, with the pulse frequency increasing from 10 pulses per second to 100 pulses per second during the pulse train.
  • electrical stimulation signals are transmitted through the abdominal electrodes 12 i and 12 s .
  • stimulus pulse trains at about 50 Hz, 0.03 msec to 0.2 msec pulse width, and up to 150 volts.
  • the pulse patterns used here may correspond to those used for functional electrical stimulation-induced coughs for paralyzed patients.
  • FIG. 3 A basic system for chest compression is shown in FIG. 3 .
  • Various modules of the motor control system shown in FIG. 3 are the startup and pre-initiation module 20 , which operates to monitor the system to detect when a user desires to use the system (sensed, for example, by removal of the device from a storage/charging unit), to initiate or startup the computer controller, to initiate communications with a remote operation center.
  • the control unit Upon initiation of the system, the control unit will monitor installation of the belt via appropriate sensors in the buckles or through other sensors.
  • the motor control module 21 receives the initiate compression signal from the control unit, the motor is started.
  • the motor in this example is run continuously, and engaged to the belt through a clutch mechanism which is controlled by the control system to repeatedly engage the belt in a take up mechanism and release the belt take up mechanism to cause the desired chest compressions. This cyclic engagement of the clutch continues repeatedly for five cycles, as recommended by current CPR guidelines, and then is interrupted for a respiration pause, if desired.
  • a feedback module 22 monitors system parameters or patient biophysical parameters used by the system to control its operation. For example, to avoid excessive drain on the batteries, the motor controller includes a torque sensor (sensing current supply to the motor, for example) and a belt length sensor, and monitors the torque or load on the motor.
  • a threshold for chest compression is established above which further compression is not desired or useful, and if this occurs during the nominal period of clutch engagement, then the clutch is disengaged and the cycle continues.
  • the system also monitors biophysical parameters such as Blood pressure, pulse, blood oxygen levels, EKG signals, end-tidal CO2, etc. and if found insufficient the system may adjust the maximum allowed compression, the pace of compression, or other parameters.
  • the cycle time and period, number of cycles between respiration pauses, and the compression limit can be set according to current guidelines, and can also be varied by the remote medical personnel via the remote control capabilities of the control unit. As indicated, after a predetermined number of cycles N (usually five compressions), the system will pause for a few seconds to allow for effective ventilation, which may be accomplished with a bag mask, mouth-to-mouth, or through the electroventilation described in this patent.
  • the system To provide for electro-stimulus including electro-counterpulsion, electroventilation, or synchronized cardioverting shock in the system, the system must be enabled to do so. By “enabled,” we mean that the system must be told that it is permitted to initiate electro-stimulus before it does so.
  • the system may be provided as a dumb automated system, a controlled system, or a smart automated system, depending on the type of electro-stimulus, and the prevailing medical preferences.
  • the counterpulsion electro-stimulus may be enabled at all times, while in a controlled automated system, the counterpulsion electro-stimulus will be enabled when the by-stander operator provides input to the system, or when the remote expert medical staff remotely enables it.
  • the counterpulsion electro-stimulus will be enabled when the system senses a biological parameter for which counterpulsion is medically indicated and automatically stopped when the sensed biological parameter indicates that counterpulsion electro-stimulus is no longer indicated.
  • cardiac arrest conditions While the condition for which counterpulsion is medically indicated will vary as the ACLS is modified over time as we gain clinical experience which indicates the optimal conditions for counterpulsion and potential risk conditions (during which counterpulsion is counterindicated), we currently consider all cardiac arrest conditions to be a condition which is an indication for counterpulsion. This condition may be sensed with EKG sensors, blood pressure sensors and pulse amplitude sensors, and feedback from these sensors may be provided to the control system for consideration by the system.
  • the electro-ventilation stimulus may be enabled at all times, while in a controlled automated system, the electro-ventilation will be enabled when the by-stander operator provides input to the system, or when the remote expert medical staff remotely enables it.
  • the electro-ventilation stimulus will be enabled when the system senses a biological parameter for which electro-ventilation is medically indicated and automatically stopped when the sensed biological parameter indicates that electro-ventilation stimulus is no longer indicated.
  • While the condition for which electro-ventilation is medically indicated will vary as the ACLS is modified over time and as we gain clinical experience which indicates the optimal conditions for electro-ventilation and potential risk conditions (during which electro-ventilation is counterindicated), we currently consider respiratory arrest to be a condition for which electro-ventilation is indicated.
  • This condition may be sensed with CO2 sensors, air flow sensors, air temperature sensors, and chest mounted impedance sensors, and feedback from these sensors may be provided to the control system for consideration by the system.
  • Control of cardioverting shock in a dumb automated system may seem undesirable in field applications, but may prove quite useful in hospital and emergency room settings.
  • a dumb automatic system in which the cardioverting shock stimulus may be enabled at all times may be operated.
  • Cardioverting shock is more likely to be successful when applied to a compressed heart, as is known by surgeons who practice open heart surgery.
  • the device may be provided in an embodiment in which it compresses the chest and applies cardioverting shock near the end of the compression period. This embodiment initiates a compression cycle when instructed to do so by the operator, and automatically applies the cardioverting shock to the patient at the optimum time near the end of the compression cycle.
  • the automatic embodiment can optionally perform CPR (and electroventilation) for a number of compression cycles, after which it automatically applies the cardioverting shock to the patient.
  • CPR electroventilation
  • the cardioverting shock is applied automatically after the compression strokes, without regard to further operator input (except for shutdown), and without regard to biological parameters.
  • the operators can reassess the patient to determine if the heart has been successfully defibrillated, and apply additionally cardioverting shocks according to accepted protocols such as the ACLS.
  • the system can be programmed to apply cardioverting shock while in a controlled automated mode.
  • the cardioverting shock will be enabled when the by-stander operator provides input to the system, or when the remote expert medical staff remotely enables it.
  • the system can be programmed to apply cardioverting shock while in a smart automated mode.
  • the cardioverting shock will be enabled when the system senses a biological parameter for which cardioverting shock is medically indicated and automatically stopped when the sensed biological parameter indicates that cardioverting shock stimulus is no longer indicated. It is clearly not desired under current ACLS guidelines to periodically defibrillate a cardiac arrest patient, so the smart automatic system will preferably use EKG signal input to determine when defibrillation is required, and when it has been successful or unsuccessful.
  • the system is programmed to perform CPR, simultaneously assess the need for defibrillation, apply the cardioverting shock, assess the success of the cardioverting shock in defibrillating the patient, and follow up with additional application of CPR if defibrillation has been unsuccessful or terminate CPR if defibrillation has been successful in restoring normal heart rhythm and blood flow.
  • the system can continue to monitor the patient EKG's, blood pressure and pulse in case of a recurrence of the fibrillation, a non-perfusing rhythm or a cessation of blood flow, in which case it is programmed to re-initiate CPR.
  • ventricular fibrillation and ventricular tachycardia are indications for cardioverting shock. These conditions may be sensed with the chest mounted EKG electrodes and acoustic sensors, and feedback from these sensors may be provided to the control system for consideration by the system.
  • Commercially available sensors, electrodes and EKG analysis systems such as the ForeRunnerTM AED sold by HP Heartstream can be used as the basis for the cardioverting subsystem.
  • FIG. 4 is a block diagram of the system software in the form of a flow chart, illustrating the programming of the system which enables it to accomplish CPR with integrated electro-counterpulsion, electroventilation and defibrillation.
  • the pre-initiation module 30 operates to monitor the system to detect when a user desires to use the system (again, by sensing removal of the device from a storage/charging unit), to initiate or startup the computer controller, to initiate communications with a remote operation center. Additional features such as authorizing access to pre-trained bystanders, automatically alerting emergency medical personnel to the event, and establishing enablement limits may be performed.
  • the system software directs the system to check physiological feedback, initialize the control parameters, ensure that the motor is off, the clutch is off and the system counter, if the system is fitted with a counter, is set at zero for the number of compressions and number of cardioverting shocks.
  • the slack take-up module 32 directs the system to spool the belt to a point where it is not slack around the patient, and record system parameters such as belt deployment length and initialize encoders used to track the amount of chest compression provided.
  • the compression module 33 controls the system to repeatedly compress the chest with the mechanisms of the chest compressing mechanism, which in our system are described in detail in our co-pending U.S. patent application Ser. No. 09/087,299 (now U.S. Pat. No. 6,066,106) and application Ser. No. 08/922,723 (now U.S. Pat. No. 6,142,962).
  • the “hold at compression” module 34 controls the system to maintain a period of static compression after each compression, if desired.
  • the system is designed to transmit a stimulating pulse to the intercostal nerves innervating the abdominal muscles when the compression stroke is complete.
  • the system checks to see if counterpulsion is enabled and, if so, it initiates a counterpulsion stimulus, as indicated by the electro-counterpulsion module 35 placement after each compression and/or static compression period.
  • the system instructs the electro-stimulation system to stimulate the abdominal muscles to cause the counterpulsion that results from contraction of the abdominal muscles.
  • the counterpulsion may be initiated immediately following the compression stroke, shortly before the end of the compression cycle, or shortly after the end of the compression cycles, or at any time between compression cycles.
  • Clutch disengagement is used as the proxy for the end of the compression period in this system, but any other system parameter may be used as a proxy for the end of the compression period.
  • motor status, brake status, pneumatic valve status (for pneumatic systems), drive piston status (for Thumper® type devices), or other actual parameters may be used.
  • the system controller is programmed to activate the counterpulsion electro-stimulus in tandem with the proxy action.
  • the system if programmed to disengage the clutch to end the compression period, initiates clutch disengagement and initiates the counterpulsion electro-stimulation at or about the same time.
  • the actual status of the proxy action may be monitored by the system, and the actual status used by the system as the signal to initiate the counterpulsion electro-stimulus.
  • the actual status may also be checked by the system and used as a double-check on the system status before initiation of the counterpulsion electro-stimulus, and in this manner the possibility that counterpulsion will be initiated during a sub-optimal portion of the chest compression/relaxation cycles is reduced.
  • the electro-counterpulsion module may be reconfigured to act as an abdominal binding module, and it may be referred to at the start of the compression module operation, and the required electro-stimulus can be applied while the compressive force is being applied to the chest.
  • the system is designed to transmit a stimulating pulse to the phrenic nerve when the compression stroke is complete.
  • the system each time the system counts a number of compressions desired between respiration pauses, the system initiates an electroventilation stimulus, as indicated by the electroventilation module 36 placement after every group of N compressions and during each respiration pause.
  • the system checks to determine if electroventilation is enabled, and if so, it instructs the electroventilation system to stimulate the phrenic nerve or the phrenicoabdominal branches (nerves directly innervating the diaphragm) to cause the electroventilation that results from contraction of the diaphragm muscles.
  • the intercostal nerves may also be stimulated to activate the intercostal muscles.
  • the block diagram for automatic defibrillation is also illustrated in FIG. 4 .
  • the system incorporates an automatic external defibrillator which is tied into the operation of the chest compression device.
  • the defibrillation module 37 may incorporate any available automatic defibrillation algorithm to determine if the EKG signals sensed by the EKG electrodes constitute a shockable rhythm (a rhythm indicating that a defibrillating shock can be expected to result in cardioversion and return of normal sinus rhythm to the heart).
  • the defibrillation module is referred to at or near the end of each active compression stroke if defibrillation has been enabled.
  • Defibrillation may be enabled in all cases, in situations where a highly trained bystander has accessed the system, or where the system has established communication with a remote medical center which, through the communication system, has enabled the defibrillation system.
  • the system may place limits on when the defibrillation module can be enabled, such as requiring a period of one to two minutes of chest compression prior to allowing application of defibrillation of shock.
  • the defibrillation module is referred to near the end of an active compression, so that the defibrillation shock can be delivered while the heart is in a relative state of compression.
  • the defibrillation module accepts feedback from installed EKG sensing electrodes and blood pressure sensors, and may adjust the defibrillation power according to current ACLS protocols. If the defibrillation system detects normal or effective EKG signals and effective blood pressure or pulse, it may then communicate to the control system or refer the system to the emergency stop module. As shown in module 37 , the decision loop 37 a will maintain the system in a holding status by referring the system back to the EKG/blood pulse monitoring sub-module continuously until the sensed signals indicate that spontaneous blood flow has failed. Failure may be indicated either by absence of proper EKG signals, indicating a non-perfusing heart rhythm, or by absence of blood pulse or blood pressure in the presence of otherwise perfusing rhythm.
  • the system is capable of detecting the condition of electro-mechanical disassociation, in which the electrical activity of the heart appears normal but proper mechanical pumping action has not been restored, and the system can continue compression after detecting this situation. (Although there appears to be little danger in compressing the chest of a revived or healthy patient, preservation of system power, patient comfort, and bystander notification will be enhanced by preventing the system from compressing/electro-stimulating a revived patient.)
  • the block diagram for cardiac pacing is also illustrated in FIG. 4 .
  • the system used for delivery of defibrillation stimulus may be used also for cardiac pacing, and is also tied into the operation of the chest compression device.
  • the pacing module 38 may incorporate any available pacing algorithm to determine if the EKG signals sensed by the EKG electrodes indicate the need for pacing.
  • bradycardia an excessively slow heart beat
  • the pacing module is referred to in the pre-initiation stage because it is expected that bradycardia can be treated with pacing alone, and delay of compression saves battery power in the event that the patient's condition degrades to the point where compression is required.
  • the pacing module periodically refers to the EKG monitoring system to determine the continuing need for pacing, or the need to move onto the device control module for compression and other electro-stimulus.
  • the pacing module may also be programmed to operate in tandem with the compression cycles of the chest compression device, in which case it is referred to at or near the end of each active compression stroke, so that the pacing shock can be delivered while the heart is in a relative state of compression.
  • Pacing may be enabled in all cases, in situations where a highly trained bystander has accessed the system, or where the system has established communication with a remote medical center which, through the communication system, has enabled the pacing system.
  • the system may place limits on when the pacing module can be enabled, such as requiring a period of one to two minutes of chest compression prior to allowing application of pacing of shock.
  • the pacing module accepts feedback from installed EKG sensing electrodes and blood pressure sensors, and may adjust the pacing power or timing within the compression cycles.
  • the block diagram for automatic glottic stimulation is also illustrated in FIG. 4 .
  • the system incorporates an automatic external recurrent laryngeal nerve stimulator which is tied into the operation of the chest compression device.
  • the glottic pacing module 39 may be referred to at or near the beginning of each active compression stroke to close the glottic opening.
  • the system checks to determine if the glottic opening control has been enabled, and, if so, initiates the delivery of electrical stimulation at the closing frequency.
  • the system instructs the electro-stimulation system to stimulate the recurrent laryngeal nerve to cause the glottis to close.
  • the stimulus is removed after each compression, as illustrated in this system. However, the stimulus may be applied for the duration of the N compressions between respiration pauses if medically indicated.
  • a stop signal may be communicated from a control panel by the bystander operating the device, or by remote medical personnel, or by automatic operation of the system.
  • Each subroutine and active module of the device (that is, modules which can instruct and operate the system to apply mechanical or electrical power to the patient) is provided with an emergency stop feature wherein each active module is programmed to check for a stop signal prior to applying mechanical or electrical power to the patient.
  • Each active module may also rely on its referring module for checking the stop signal.
  • the compression module 33 initiates its first compression relying upon the stop signal check performed in the slack take-up module 32 prior to reference from the slack take-up module 32 to the compression module. Thereafter, the compression module relies upon emergency stop check 40 within the compression module.
  • the system Upon sensing an emergency stop signal, the system refers to the emergency stop module 41 .
  • the emergency stop module then operates the system to put it into a safe condition. This includes operating the mechanical system to release compression of the body by turning off the system or controlling operation of the system to pay out the compression belt so that it exerts little or no force on the body, then disabling further compression. It also includes disabling or turning off the electroventilation, electro-counterpulsion, and defibrillation modules so that they will not apply electrical stimulation to the body.
  • the shut down preferably maintains sensing, communications, display and system initiation modules in operation so that the bystanders may determine the status of the patient, and possibly re-initiate compression if needed.
  • control system modules depend on sensed electrical signals from the patient or from the compression device.
  • the power required for defibrillation, electro-stimulus of the respiratory system, and pacing represent electrical surges of significant power relative to the sensing systems.
  • the feedback devices used to provide information to the system should be protected with circuitry which isolates the necessary signal processing systems from electrical signals with voltage or current far in excess of the expected feedback signals.
  • the term electro-stimulation system may refer to a system that stimulates the vagal nerve at any point, the phrenic nerve at any point, the abdominal muscle nerves, or the heart from any point on or within the body.
  • the electrical pulse generator may provide a pulse intended to stimulate a nerve which controls a muscle or muscle group (as with the phrenic nerves) or it may be intended to affect the electrical activity of the heart (as with a pacing stimulus or a cardioverting shock).
  • the chest compression device used may be the circumferential belt and the drive system illustrated in our patents, such as U.S. Pat. No. 6,066,106, or our co-pending patent applications, such as application Ser. Nos. 09/345,645 (now U.S. Pat. No.
  • the compression device may be a pneumatic bladder, a reciprocating piston or other system.
  • the block diagram of FIG. 4 can readily be adapted to control those mechanisms, and the complimentary electro-stimulation modules can be controlled in coordination with the particular mechanical system used.
  • the chest compression device actually exert a force on the chest to expand the chest. It is sufficient for the device to cause expansion of the chest by releasing the compression force exerted on the chest during the compression portion of the cycle, thereby permitting the natural elasticity of the thoracic cavity to lead to chest expansion.
  • systems providing active compression/decompression which actually exert a force on the chest to expand the chest (usually a suction force) may also be incorporated into the system.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Critical Care (AREA)
  • Physiology (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A device for performing chest compressions for CPR in coordination with applying electro-stimulus for additional resuscitative actions such as electro-ventilation, electro-counterpulsion, and defibrillation. The device includes a chest compression mechanism, electrodes and power supply for electro-stimulus, and a control system for applying electro-stimulus in coordination with the action of the chest compression mechanism.

Description

  • This application is a continuation of U.S. application Ser. No. 11/374,855, filed Mar. 13, 2006, now U.S. Pat. No. 7,497,837 which is a continuation of U.S. application Ser. No. 10/648,007, filed Aug. 25, 2003, now U.S. Pat. No. 7,011,637 which is a continuation of U.S. application Ser. No. 09/829,859, filed Apr. 9, 2001, now abandoned, which is a continuation of U.S. application Ser. No. 09/100,840, filed Jun. 19, 1998, now U.S. Pat. No. 6,213,960.
  • FIELD OF THE INVENTIONS
  • This invention relates to the resuscitation of cardiac arrest victims.
  • BACKGROUND OF THE INVENTIONS
  • Cardiopulmonary resuscitation (CPR) is a well known and valuable method of first aid. CPR is used to resuscitate people who have suffered from cardiac arrest after heart attack, electric shock, chest injury and many other causes. During cardiac arrest, the heart stops pumping blood, and a person suffering cardiac arrest will soon suffer brain damage from lack of blood supply to the brain. Thus, CPR requires repetitive chest compression to squeeze the heart and the thoracic cavity to pump blood through the body. Very often, the victim is not breathing, and mouth to mouth artificial respiration or a bag valve mask is used to supply air to the lungs while the chest compression pumps blood through the body. The methods of providing oxygenated airflow to the lungs are referred to as ventilation.
  • It has been widely noted that CPR and chest compression can save cardiac arrest victims, especially when applied immediately after cardiac arrest. Chest compression requires that the person providing chest compression repetitively push down on the sternum of the victim at 80-100 compressions per minute. CPR and closed chest compression can be used anywhere, wherever the cardiac arrest victim is stricken. In the field, away from the hospital, CPR may be accomplished by ill-trained by-standers or highly trained paramedics and ambulance personnel.
  • When a first aid provider performs chest compression well, blood flow in the body is typically about 25-30% of normal blood flow. This is enough blood flow to prevent brain damage. However, when chest compression is required for long periods of time, it is difficult if not impossible to maintain adequate compression of the heart and rib cage. Even experienced paramedics cannot maintain adequate chest compression for more than a few minutes. Hightower, et al., Decay In Quality Of Chest Compressions Over Time, 26 Ann. Emerg. Med. 300 (September 1995). Thus, long periods of CPR, when required, are not often successful at sustaining or reviving the victim. At the same time, it appears that, if chest compression could be adequately maintained, cardiac arrest victims could be sustained for extended periods of time. Occasional reports of extended CPR efforts (45-90 minutes) have been reported, with the victims eventually being saved by coronary bypass surgery. See Tovar, et al., Successful Myocardial Revascularization and Neurologic Recovery, 22 Texas Heart J. 271 (1995).
  • In efforts to provide better blood flow and increase the effectiveness of bystander resuscitation efforts, modifications of the basic CPR procedure have been proposed and used. Various devices and methods described below are proposed for use in a main operative activity of CPR, namely repetitive compression of the thoracic cavity.
  • The device shown in Barkalow, Cardiopulmonary resuscitator Massager Pad, U.S. Pat. No. 4,570,615 (Feb. 18, 1986), the commercially available Thumper device, and other such devices, provide continuous automatic closed chest compression. Barkalow and others provide a piston which is placed over the chest cavity and supported by an arrangement of beams. The piston is placed over the sternum of a patient and set to repeatedly push downward on the chest under pneumatic power. The victim must first be installed into the device, and the height and stroke length of the piston must be adjusted for the patient before use, leading to delay in chest compression. Other analogous devices provide for hand operated piston action on the sternum. Everette, External Cardiac Compression Device, U.S. Pat. No. 5,257,619 (Nov. 2, 1993), for example, provides a simple chest pad mounted on a pivoting arm supported over a patient, which can be used to compress the chest by pushing down in the pivoting arm. These devices are not clinically more successful than manual chest compression. See Taylor, et al., External Cardiac Compression, A Randomized Comparison of Mechanical and Manual Techniques, 240 JAMA 644 (August 1978). Other devices for mechanical compression of the chest provide a compressing piston which is secured in place over the sternum via vests or straps around the chest. Woudenberg, Cardiopulmonary Resuscitator, U.S. Pat. No. 4,664,098 (May 12, 1987) shows such a device which is powered with an air cylinder. Waide, et al., External Cardiac Massage Device, U.S. Pat. No. 5,399,148 (Mar. 21, 1995) shows another such device which is manually operated.
  • Lach, et al., Resuscitation Method and Apparatus, U.S. Pat. No. 4,770,164 (Sep. 13, 1988) proposed compression of the chest with wide band and chocks on either side of the back, applying a side-to-side clasping action on the chest to compress the chest. Kelly, et al., Chest Compression Apparatus for Cardiac Arrest, U.S. Pat. No. 5,738,637 (U.S. Pat. No. 5,738,673) proposed compression of the chest using a wide band repeatedly tightened about the chest with a lever assembly placed on the patients sternum and operated manually. The Kelly devices comprises a base which is placed over a central region of the chest, a belt which is wrapped around the patients chest and fastened at its opposite ends to the base, and a force converter connected to the base and the belt, and a manual actuator, so that the force converter converts the downward force on the manual actuators into chest compressing resultants directed toward the chest and directed tangentially to the chest. Although Kelly illustrates installation of defibrillation electrodes on the wide band, he does not suggest integrating use of the electrodes with use of the compression belt in any manner.
  • In another variation of such devices, a vest or belt designed for placement around the chest is provided with pneumatic bladders which are filled to exert compressive forces on the chest. Scarberry, Apparatus for Application of Pressure to a Human Body, U.S. Pat. No. 5,222,478 (Jun. 29, 1993) and Halperin, Cardiopulmonary Resuscitation and Assisted Circulation System, U.S. Pat. No. 4,928,674 (May 29, 1990) show examples of such devices. Halperin, for example, uses a vest fitted with air bladders that are repeatedly inflated to compress the chest. The bladders are deflated by application of a vacuum. Cyclic inflation and deflation of the vest is accomplished with a complicated arrangement of two-way and three-way valves, connected to the bladders within the vest with large bore hoses.
  • Our own CPR devices use a compression belt around the chest of the patient which is repetitively tightened and relaxed through the action of a belt tightening spool powered by an electric motor. The motor is controlled by control system which times the compression cycles, limits the torque applied by the system (thereby limiting the power of the compression applied to the victim), provides for adjustment of the torque limit based on biological feedback from the patient, provides for respiration pauses, and controls the compression pattern through an assembly of clutches and/or brakes connecting the motor to the belt spool. Our devices have achieved high levels of blood flow in animal studies.
  • Abdominal binding is a technique used to enhance the effectiveness of the CPR chest compression. Abdominal binding is achieved by binding the stomach during chest compression to limit the waste of compressive force which is lost to deformation of the abdominal cavity caused by the compression of the chest. It also inhibits flow of blood into the lower extremities (and promotes bloodflow to the brain). Alferness, Manually-Actuable CPR apparatus, U.S. Pat. No. 4,349,015 (Sep. 14, 1982) provides for abdominal restraint during the compression cycle with a bladder that is filled during compression. Counterpulsion is a method in which slight pressure is applied to the abdomen in between each chest compression. A manual device for counterpulsion is shown in Shock, et al., Active Compression/Decompression Device for Cardiopulmonary Resuscitation, U.S. Pat. No. 5,630,789 (May 20, 1997). This device is like a seesaw mounted over the chest with a contact cup on each end of the seesaw. One end of the seesaw is mounted over the chest, and the other end is mounted over the abdomen, and the device is operated by rocking back and forth, alternately applying downward force on each end.
  • Electroventilation is the process of ventilating a patient by electrically stimulating the nerves that control the muscles used for respiration. It is proposed for use in patients that have been paralyzed such that the normal motor impulses transmitted to the diaphragm are not transmitted. Geddes, Demand Electroventilator, U.S. Pat. No. 4,827,935 (May 9, 1989) illustrates the operation of an electroventilator. He illustrates placement of two electrodes on the chest (one on either side), and application of electrical stimulus through the electrodes to stimulate the nerves responsible for triggering the muscles used in respiration. Geddes system provided for smooth inspiration, which was an improvement over the sharp gasping action caused by earlier electroventilation systems. The nerves identified by Geddes are the phrenic nerve, which controls the diaphragm, and the intercostal nerves which control the intercostal muscles (muscles between the ribs).
  • SUMMARY
  • The devices and methods described below combine mechanisms for compressing the chest with electrical devices for conducting other beneficial components of cardiopulmonary resuscitation and the ACLS protocol. A set of electrodes is provided on the neck and/or chest of the patient for electrically stimulating the diaphragm to provide an inhalation, thereby ventilating the patient, and a control system provides for coordination of the ventilating stimulus with the compression system so that ventilation is initiated during ventilation pauses in the compression pattern (these compression pauses would normally be used for mouth-to-mouth or bag ventilation). A set of electrodes is provided for installation over the patient's abdomen, to cause contraction of the abdominal muscles, and a control system provides for coordination of the abdominal muscle stimulation and the chest compression mechanism in order to effect abdominal binding or counterpulsion. A set of electrodes is provided for defibrillating the patient, and a control system is provided for coordinating the initiating the defibrillation shock in sync with the chest compression mechanism. The defibrillation electrodes may be used for pacing the heart. Additional electrodes may be supplied for control of the glottic opening. An overall control system is provided for coordinating the action of the chest compression device with the operation of various electrical stimulus devices to enhance the effectiveness of the resuscitation regimen.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is diagram of a typical chest compression device.
  • FIG. 2 is diagram of a typical patient illustrating the electrode placement.
  • FIG. 3 is a block diagram of the motor control system for use for basic CPR chest compression.
  • FIG. 4A is a block diagram of the motor control system for use in electro-ventilation during respiration pauses of the compression system, for use in electro-counterpulsion during operation of the compression system, and for use in the synchronized cardioverting shock system.
  • FIG. 4B is a continuation of FIG. 4A.
  • DETAILED DESCRIPTION OF THE INVENTIONS
  • FIG. 1 shows the system mounted on a patient 1 and ready for use. The chest compression subsystem 2 comprises the motor box 3, the belt cartridge 4, and the compression belt 5 with left and right portions 5L and 5R. The belt is fastened around the patient with fasteners 6, which may be buckles, Velcro® hook and loop fasteners or other fasteners with sensors to sense when the belt is fastened. Ventilation electrodes 7L and 7R are mounted on the belts in the area of the lower chest, over the diaphragm, placed bilaterally. Bipolar electrodes 8L and 8R (or electrode pairs) may also be placed on the neck, bilaterally, to stimulate the phrenic nerve which courses downwardly through the neck. Defibrillation electrodes 9R and 9L are placed in the right sternum parasaggital location 10 and left rib medial location 11, and they may also be located below the patient, on the spine between the shoulder blades, and on the center of the chest, respectively. These electrodes are also used for establishing the electrical contact needed for EKG sensing. Counterpulsion electrodes 12 i and 12 s are placed on the skin over the abdominal or rectus muscles, with a line of positive electrodes placed in the superior position and a line of ground electrodes placed in the inferior position. Glottic control electrodes are disposed on electrode patch 13 placed on the neck along the tracheo-esophageal groove.
  • FIG. 2 illustrates the nerves of the human body upon which the electro-stimulation system may act. The phrenic nerves 14L and 14R are believed to be used by the body to control the diaphragm 15. The phrenic nerves course from the neck 16, superficially over the scalene muscles, and deep within the chest around the heart to the diaphragm. The phrenic nerves divide into the phrenicoabdominal branches 17. The phrenic nerves comprise both efferent and afferent nerves which run together along their common course. The phrenic nerves and the diaphragm are principal components of breathing. Other nerves and muscles which are used in breathing are the intercostal nerves, located between the ribs 18 and controlling the external intercostal muscles, and the internal intercostal muscles. The abdominal muscles 19, controlled by intercostal nerves, are used in active breathing. The electrodes 7L and 7R, 8L and 8R, 9L and 9R, 12 i and 12 s, and 13 are illustrated in the appropriate positions as viewed from the front of the patient.
  • The airway is controlled by the glottic opening (including the vocal cords) which is controlled by the recurrent laryngeal nerve. The operation of the glottis is not typically impaired in cardiac arrest patients. However, its operation can be influenced by electrical stimulation of the recurrent laryngeal nerves, and closure during the compression period of the CPR device enhances intrathoracic pressure. The recurrent laryngeal nerve may be stimulated with electrical stimulation delivered most conveniently through an electrode mounted on the skin of the neck, along the tracheo-esophageal groove. It may also be activated from inside the throat of the patient by applying electrical stimulation directly to the vocal cords, or through the tracheal wall or the esophageal wall (with electrodes mounted on an ET tube, which is routinely inserted by emergency medical technicians). Stimulation of the RLN will open or close the glottic opening depending on the frequency of the applied electrical stimulus. For transcutaneous stimulation, stimulation at frequencies below 30 Hertz cause the vocal cord to open, while stimulation at frequencies from 40-100 Hertz will cause the vocal cords to close. Stimulation with pulses ranging up to 20 milli-amps and pulses of 0.5 msec to 2 msec duration should be effective to stimulate closure of the glottic opening.
  • There are two electrical mechanisms that can be used to activate a muscle within the body, and the systems described below can allow for both. First, the motor nerve (such as the phrenic nerve) is used by the body to transmit a nervous system impulse to activating nerves which directly innervate the muscles. The motor nerves may be stimulated by an electrical pulse to cause the motor nerve to stimulate the activating nerves within the muscle to be contracted. Second, the activating nerves that directly innervate the muscles may be locally stimulated to cause muscle contraction. The diaphragm, the intercostal muscles, and the abdominal muscles may be stimulated with both electrical mechanisms.
  • The CPR device illustrated in FIG. 1 stimulates the motor nerve and the activating nerves, either singly or together, to cause contraction of the diaphragm, the intercostal muscles, and the abdominal muscles. The diaphragm and the intercostal muscles are stimulated in coordination with the compression mechanism to cause those muscles to cause an inhalation. The abdominal muscles are stimulated in coordination with the compression mechanism to make those muscles contract. The contraction of the abdominal muscles results in a binding of the abdomen that, when syncopated with chest compressions provides an electrically induced version of counterpulsion which increases the effectiveness of the chest compression mechanism in creating blood flow within a patient.
  • The manner in which electrical stimulation may be applied may vary considerably and yet still provide effective activation of the muscle groups involved. The electrical stimulation is preferably applied in repeated bursts comprising a number of pulses. The pulses are characterized by their pulse width and pulse amplitude (current or voltage). The pulse bursts, or pulse trains, may be characterized by the pulse train width and the number of pulse bursts per second. In each instance, the pulses employed may be monophasic, biphasic, or polyphasic, according to medical indications at the time of use. The pulses may be DC pulses or AC pulses of varying frequency.
  • For stimulation of the respiratory muscles, we prefer an electrical pulse pattern which causes a smooth inhalation. The respiratory stimulation is provided through the electrodes 8L and 8R on the neck or electrodes 7L and 7R over the general area of the diaphragm. When electrical stimulation is supplied through the chest electrodes, the electrical stimulation may be provided in single amplitude pulse trains containing numerous pulses of 0.03 msec pulse width, delivered at 60 pulses per second, delivered at amplitude up to one amp. Preferably, a linearly ramped pulse train with an initial amplitude of about 10-50 milli-amps and a final amplitude of about 100-200 milli-amps, with pulse widths of 0.01 to 0.1 msec, and 60 pulses per second, with pulse train of 0.5 to 2 seconds. A frequency modulated pulse train may also be used, with a pulse train of about 1 second, individual pulses of 0.01 msec to 0.1 msec, an amplitude of 50-200 milli-amps, with the pulse frequency increasing from 10 pulses per second to 100 pulses per second during the pulse train. These pulse patterns will provide for smooth inhalation and minimal potential for interference with the proper electrical operation of the heart.
  • For stimulation of the abdominal muscles, electrical stimulation signals are transmitted through the abdominal electrodes 12 i and 12 s. For the contraction of these muscles, stimulus pulse trains at about 50 Hz, 0.03 msec to 0.2 msec pulse width, and up to 150 volts. The pulse patterns used here may correspond to those used for functional electrical stimulation-induced coughs for paralyzed patients.
  • A basic system for chest compression is shown in FIG. 3. Various modules of the motor control system shown in FIG. 3 are the startup and pre-initiation module 20, which operates to monitor the system to detect when a user desires to use the system (sensed, for example, by removal of the device from a storage/charging unit), to initiate or startup the computer controller, to initiate communications with a remote operation center. Upon initiation of the system, the control unit will monitor installation of the belt via appropriate sensors in the buckles or through other sensors. When the motor control module 21 receives the initiate compression signal from the control unit, the motor is started. The motor in this example is run continuously, and engaged to the belt through a clutch mechanism which is controlled by the control system to repeatedly engage the belt in a take up mechanism and release the belt take up mechanism to cause the desired chest compressions. This cyclic engagement of the clutch continues repeatedly for five cycles, as recommended by current CPR guidelines, and then is interrupted for a respiration pause, if desired. A feedback module 22 monitors system parameters or patient biophysical parameters used by the system to control its operation. For example, to avoid excessive drain on the batteries, the motor controller includes a torque sensor (sensing current supply to the motor, for example) and a belt length sensor, and monitors the torque or load on the motor. A threshold for chest compression is established above which further compression is not desired or useful, and if this occurs during the nominal period of clutch engagement, then the clutch is disengaged and the cycle continues. The system also monitors biophysical parameters such as Blood pressure, pulse, blood oxygen levels, EKG signals, end-tidal CO2, etc. and if found insufficient the system may adjust the maximum allowed compression, the pace of compression, or other parameters. The cycle time and period, number of cycles between respiration pauses, and the compression limit, can be set according to current guidelines, and can also be varied by the remote medical personnel via the remote control capabilities of the control unit. As indicated, after a predetermined number of cycles N (usually five compressions), the system will pause for a few seconds to allow for effective ventilation, which may be accomplished with a bag mask, mouth-to-mouth, or through the electroventilation described in this patent.
  • To provide for electro-stimulus including electro-counterpulsion, electroventilation, or synchronized cardioverting shock in the system, the system must be enabled to do so. By “enabled,” we mean that the system must be told that it is permitted to initiate electro-stimulus before it does so. The system may be provided as a dumb automated system, a controlled system, or a smart automated system, depending on the type of electro-stimulus, and the prevailing medical preferences.
  • For control of counterpulsion electro-stimulus in a dumb automated system, the counterpulsion electro-stimulus may be enabled at all times, while in a controlled automated system, the counterpulsion electro-stimulus will be enabled when the by-stander operator provides input to the system, or when the remote expert medical staff remotely enables it. In a smart automated system, the counterpulsion electro-stimulus will be enabled when the system senses a biological parameter for which counterpulsion is medically indicated and automatically stopped when the sensed biological parameter indicates that counterpulsion electro-stimulus is no longer indicated. While the condition for which counterpulsion is medically indicated will vary as the ACLS is modified over time as we gain clinical experience which indicates the optimal conditions for counterpulsion and potential risk conditions (during which counterpulsion is counterindicated), we currently consider all cardiac arrest conditions to be a condition which is an indication for counterpulsion. This condition may be sensed with EKG sensors, blood pressure sensors and pulse amplitude sensors, and feedback from these sensors may be provided to the control system for consideration by the system.
  • For control of electro-ventilation in a dumb automated system, the electro-ventilation stimulus may be enabled at all times, while in a controlled automated system, the electro-ventilation will be enabled when the by-stander operator provides input to the system, or when the remote expert medical staff remotely enables it. In a smart automated system, the electro-ventilation stimulus will be enabled when the system senses a biological parameter for which electro-ventilation is medically indicated and automatically stopped when the sensed biological parameter indicates that electro-ventilation stimulus is no longer indicated. While the condition for which electro-ventilation is medically indicated will vary as the ACLS is modified over time and as we gain clinical experience which indicates the optimal conditions for electro-ventilation and potential risk conditions (during which electro-ventilation is counterindicated), we currently consider respiratory arrest to be a condition for which electro-ventilation is indicated. This condition may be sensed with CO2 sensors, air flow sensors, air temperature sensors, and chest mounted impedance sensors, and feedback from these sensors may be provided to the control system for consideration by the system.
  • Control of cardioverting shock in a dumb automated system may seem undesirable in field applications, but may prove quite useful in hospital and emergency room settings. Thus, a dumb automatic system in which the cardioverting shock stimulus may be enabled at all times may be operated. Cardioverting shock is more likely to be successful when applied to a compressed heart, as is known by surgeons who practice open heart surgery. To take advantage of this fact, the device may be provided in an embodiment in which it compresses the chest and applies cardioverting shock near the end of the compression period. This embodiment initiates a compression cycle when instructed to do so by the operator, and automatically applies the cardioverting shock to the patient at the optimum time near the end of the compression cycle. Additionally, because cardioverting shock is more likely to succeed when applied after a period of CPR, the automatic embodiment can optionally perform CPR (and electroventilation) for a number of compression cycles, after which it automatically applies the cardioverting shock to the patient. In a dumb automated system, the cardioverting shock is applied automatically after the compression strokes, without regard to further operator input (except for shutdown), and without regard to biological parameters. After the cardioverting shock is applied, the operators can reassess the patient to determine if the heart has been successfully defibrillated, and apply additionally cardioverting shocks according to accepted protocols such as the ACLS.
  • The system can be programmed to apply cardioverting shock while in a controlled automated mode. The cardioverting shock will be enabled when the by-stander operator provides input to the system, or when the remote expert medical staff remotely enables it. The system can be programmed to apply cardioverting shock while in a smart automated mode. In a smart automated system, the cardioverting shock will be enabled when the system senses a biological parameter for which cardioverting shock is medically indicated and automatically stopped when the sensed biological parameter indicates that cardioverting shock stimulus is no longer indicated. It is clearly not desired under current ACLS guidelines to periodically defibrillate a cardiac arrest patient, so the smart automatic system will preferably use EKG signal input to determine when defibrillation is required, and when it has been successful or unsuccessful. The system is programmed to perform CPR, simultaneously assess the need for defibrillation, apply the cardioverting shock, assess the success of the cardioverting shock in defibrillating the patient, and follow up with additional application of CPR if defibrillation has been unsuccessful or terminate CPR if defibrillation has been successful in restoring normal heart rhythm and blood flow. The system can continue to monitor the patient EKG's, blood pressure and pulse in case of a recurrence of the fibrillation, a non-perfusing rhythm or a cessation of blood flow, in which case it is programmed to re-initiate CPR. While the condition for which cardioverting shock is medically indicated will vary as the ACLS is modified over time as we gain clinical experience which indicates the optimal conditions for cardioverting shock and potential risk conditions (during which cardioverting shock is counterindicated), we currently consider ventricular fibrillation and ventricular tachycardia to be a conditions which are indications for cardioverting shock. These conditions may be sensed with the chest mounted EKG electrodes and acoustic sensors, and feedback from these sensors may be provided to the control system for consideration by the system. Commercially available sensors, electrodes and EKG analysis systems such as the ForeRunner™ AED sold by HP Heartstream can be used as the basis for the cardioverting subsystem.
  • FIG. 4 is a block diagram of the system software in the form of a flow chart, illustrating the programming of the system which enables it to accomplish CPR with integrated electro-counterpulsion, electroventilation and defibrillation. The pre-initiation module 30 operates to monitor the system to detect when a user desires to use the system (again, by sensing removal of the device from a storage/charging unit), to initiate or startup the computer controller, to initiate communications with a remote operation center. Additional features such as authorizing access to pre-trained bystanders, automatically alerting emergency medical personnel to the event, and establishing enablement limits may be performed. For instance, it may be advisable to permit electroventilation and electro-counterpulsion to be performed automatically by the system when accessed by moderately trained bystanders, and permit automatic defibrillation only when the system is accessed by highly trained bystanders, emergency medical technicians, nurses or doctors. In the system initialization module 31, the system software directs the system to check physiological feedback, initialize the control parameters, ensure that the motor is off, the clutch is off and the system counter, if the system is fitted with a counter, is set at zero for the number of compressions and number of cardioverting shocks. The slack take-up module 32 directs the system to spool the belt to a point where it is not slack around the patient, and record system parameters such as belt deployment length and initialize encoders used to track the amount of chest compression provided. The compression module 33 controls the system to repeatedly compress the chest with the mechanisms of the chest compressing mechanism, which in our system are described in detail in our co-pending U.S. patent application Ser. No. 09/087,299 (now U.S. Pat. No. 6,066,106) and application Ser. No. 08/922,723 (now U.S. Pat. No. 6,142,962). The “hold at compression” module 34 controls the system to maintain a period of static compression after each compression, if desired.
  • To provide for counterpulsion in this exemplary system, the system is designed to transmit a stimulating pulse to the intercostal nerves innervating the abdominal muscles when the compression stroke is complete. Thus, each time the clutch disengages, the system checks to see if counterpulsion is enabled and, if so, it initiates a counterpulsion stimulus, as indicated by the electro-counterpulsion module 35 placement after each compression and/or static compression period. Thus, after each hold period, which signifies the end of the compression stroke and the end of each hold period, the system instructs the electro-stimulation system to stimulate the abdominal muscles to cause the counterpulsion that results from contraction of the abdominal muscles. The counterpulsion may be initiated immediately following the compression stroke, shortly before the end of the compression cycle, or shortly after the end of the compression cycles, or at any time between compression cycles. Clutch disengagement is used as the proxy for the end of the compression period in this system, but any other system parameter may be used as a proxy for the end of the compression period. For example, motor status, brake status, pneumatic valve status (for pneumatic systems), drive piston status (for Thumper® type devices), or other actual parameters may be used. The system controller is programmed to activate the counterpulsion electro-stimulus in tandem with the proxy action. In other words, the system, if programmed to disengage the clutch to end the compression period, initiates clutch disengagement and initiates the counterpulsion electro-stimulation at or about the same time. (If desired, the actual status of the proxy action may be monitored by the system, and the actual status used by the system as the signal to initiate the counterpulsion electro-stimulus. The actual status may also be checked by the system and used as a double-check on the system status before initiation of the counterpulsion electro-stimulus, and in this manner the possibility that counterpulsion will be initiated during a sub-optimal portion of the chest compression/relaxation cycles is reduced.)
  • It may be advantageous to stimulate the abdominal muscles into contraction at varying points in the compression cycle. Abdominal binding may be affected by applying the electro-stimulus pulse to the abdominal muscles near the beginning of the chest compression. If this is desired, the electro-counterpulsion module may be reconfigured to act as an abdominal binding module, and it may be referred to at the start of the compression module operation, and the required electro-stimulus can be applied while the compressive force is being applied to the chest.
  • To provide for electroventilation in this exemplary system, the system is designed to transmit a stimulating pulse to the phrenic nerve when the compression stroke is complete. Thus, each time the system counts a number of compressions desired between respiration pauses, the system initiates an electroventilation stimulus, as indicated by the electroventilation module 36 placement after every group of N compressions and during each respiration pause. Thus, during each respiration pause, the system checks to determine if electroventilation is enabled, and if so, it instructs the electroventilation system to stimulate the phrenic nerve or the phrenicoabdominal branches (nerves directly innervating the diaphragm) to cause the electroventilation that results from contraction of the diaphragm muscles. The intercostal nerves may also be stimulated to activate the intercostal muscles.
  • The block diagram for automatic defibrillation is also illustrated in FIG. 4. The system incorporates an automatic external defibrillator which is tied into the operation of the chest compression device. The defibrillation module 37 may incorporate any available automatic defibrillation algorithm to determine if the EKG signals sensed by the EKG electrodes constitute a shockable rhythm (a rhythm indicating that a defibrillating shock can be expected to result in cardioversion and return of normal sinus rhythm to the heart). The defibrillation module is referred to at or near the end of each active compression stroke if defibrillation has been enabled. Defibrillation may be enabled in all cases, in situations where a highly trained bystander has accessed the system, or where the system has established communication with a remote medical center which, through the communication system, has enabled the defibrillation system. The system may place limits on when the defibrillation module can be enabled, such as requiring a period of one to two minutes of chest compression prior to allowing application of defibrillation of shock. The defibrillation module is referred to near the end of an active compression, so that the defibrillation shock can be delivered while the heart is in a relative state of compression. The defibrillation module accepts feedback from installed EKG sensing electrodes and blood pressure sensors, and may adjust the defibrillation power according to current ACLS protocols. If the defibrillation system detects normal or effective EKG signals and effective blood pressure or pulse, it may then communicate to the control system or refer the system to the emergency stop module. As shown in module 37, the decision loop 37 a will maintain the system in a holding status by referring the system back to the EKG/blood pulse monitoring sub-module continuously until the sensed signals indicate that spontaneous blood flow has failed. Failure may be indicated either by absence of proper EKG signals, indicating a non-perfusing heart rhythm, or by absence of blood pulse or blood pressure in the presence of otherwise perfusing rhythm. Thus the system is capable of detecting the condition of electro-mechanical disassociation, in which the electrical activity of the heart appears normal but proper mechanical pumping action has not been restored, and the system can continue compression after detecting this situation. (Although there appears to be little danger in compressing the chest of a revived or healthy patient, preservation of system power, patient comfort, and bystander notification will be enhanced by preventing the system from compressing/electro-stimulating a revived patient.)
  • The block diagram for cardiac pacing is also illustrated in FIG. 4. The system used for delivery of defibrillation stimulus may be used also for cardiac pacing, and is also tied into the operation of the chest compression device. The pacing module 38 may incorporate any available pacing algorithm to determine if the EKG signals sensed by the EKG electrodes indicate the need for pacing. Currently, bradycardia (an excessively slow heart beat) is considered the primary indication for pacing. The pacing module is referred to in the pre-initiation stage because it is expected that bradycardia can be treated with pacing alone, and delay of compression saves battery power in the event that the patient's condition degrades to the point where compression is required. The pacing module periodically refers to the EKG monitoring system to determine the continuing need for pacing, or the need to move onto the device control module for compression and other electro-stimulus. (The pacing module may also be programmed to operate in tandem with the compression cycles of the chest compression device, in which case it is referred to at or near the end of each active compression stroke, so that the pacing shock can be delivered while the heart is in a relative state of compression.)
  • Pacing may be enabled in all cases, in situations where a highly trained bystander has accessed the system, or where the system has established communication with a remote medical center which, through the communication system, has enabled the pacing system. The system may place limits on when the pacing module can be enabled, such as requiring a period of one to two minutes of chest compression prior to allowing application of pacing of shock. The pacing module accepts feedback from installed EKG sensing electrodes and blood pressure sensors, and may adjust the pacing power or timing within the compression cycles.
  • The block diagram for automatic glottic stimulation is also illustrated in FIG. 4. The system incorporates an automatic external recurrent laryngeal nerve stimulator which is tied into the operation of the chest compression device. The glottic pacing module 39 may be referred to at or near the beginning of each active compression stroke to close the glottic opening. The system checks to determine if the glottic opening control has been enabled, and, if so, initiates the delivery of electrical stimulation at the closing frequency. Thus, just before each compression period (depending on medical indications at the time of use), the system instructs the electro-stimulation system to stimulate the recurrent laryngeal nerve to cause the glottis to close. The stimulus is removed after each compression, as illustrated in this system. However, the stimulus may be applied for the duration of the N compressions between respiration pauses if medically indicated.
  • Throughout the block diagram of FIG. 4, the system checks for input of a stop signal. A stop signal may be communicated from a control panel by the bystander operating the device, or by remote medical personnel, or by automatic operation of the system. Each subroutine and active module of the device (that is, modules which can instruct and operate the system to apply mechanical or electrical power to the patient) is provided with an emergency stop feature wherein each active module is programmed to check for a stop signal prior to applying mechanical or electrical power to the patient. Each active module may also rely on its referring module for checking the stop signal. For example, the compression module 33 initiates its first compression relying upon the stop signal check performed in the slack take-up module 32 prior to reference from the slack take-up module 32 to the compression module. Thereafter, the compression module relies upon emergency stop check 40 within the compression module.
  • Upon sensing an emergency stop signal, the system refers to the emergency stop module 41. The emergency stop module then operates the system to put it into a safe condition. This includes operating the mechanical system to release compression of the body by turning off the system or controlling operation of the system to pay out the compression belt so that it exerts little or no force on the body, then disabling further compression. It also includes disabling or turning off the electroventilation, electro-counterpulsion, and defibrillation modules so that they will not apply electrical stimulation to the body. The shut down preferably maintains sensing, communications, display and system initiation modules in operation so that the bystanders may determine the status of the patient, and possibly re-initiate compression if needed.
  • Several of the control system modules depend on sensed electrical signals from the patient or from the compression device. However, the power required for defibrillation, electro-stimulus of the respiratory system, and pacing represent electrical surges of significant power relative to the sensing systems. For this reason, the feedback devices used to provide information to the system should be protected with circuitry which isolates the necessary signal processing systems from electrical signals with voltage or current far in excess of the expected feedback signals.
  • The term electro-stimulation system may refer to a system that stimulates the vagal nerve at any point, the phrenic nerve at any point, the abdominal muscle nerves, or the heart from any point on or within the body. The electrical pulse generator may provide a pulse intended to stimulate a nerve which controls a muscle or muscle group (as with the phrenic nerves) or it may be intended to affect the electrical activity of the heart (as with a pacing stimulus or a cardioverting shock). The chest compression device used may be the circumferential belt and the drive system illustrated in our patents, such as U.S. Pat. No. 6,066,106, or our co-pending patent applications, such as application Ser. Nos. 09/345,645 (now U.S. Pat. No. 6,398,745) and 09/866,377 (now U.S. Pat. No. 6,616,620), or the compression device may be a pneumatic bladder, a reciprocating piston or other system. In this case, the block diagram of FIG. 4 can readily be adapted to control those mechanisms, and the complimentary electro-stimulation modules can be controlled in coordination with the particular mechanical system used.
  • It is not necessary that the chest compression device actually exert a force on the chest to expand the chest. It is sufficient for the device to cause expansion of the chest by releasing the compression force exerted on the chest during the compression portion of the cycle, thereby permitting the natural elasticity of the thoracic cavity to lead to chest expansion. However, systems providing active compression/decompression, which actually exert a force on the chest to expand the chest (usually a suction force) may also be incorporated into the system.
  • Thus, while the preferred embodiments of the devices and methods have been described in reference to the environment in which they were developed, they are merely illustrative of the principles of the inventions. Other embodiments and configurations may be devised without departing from the spirit of the inventions and the scope of the appended claims.

Claims (5)

1. A device for resuscitating a patient comprising:
a chest compression device capable of repeatedly compressing the chest of the patient and causing or allowing the chest to expand;
an electro-stimulation system including defibrillating electrodes connecting the electro-stimulation system to the patient and an electrical generator;
a controller for coordinating and controlling the chest compression device and the electro-stimulation system to apply electro-stimulation to the defibrillating electrodes after a period of static compression when the chest is allowed to expand.
2. The device of claim 1 wherein the controller comprises:
a controller for coordinating and controlling the chest compression device and the electro-stimulation system to apply electro-stimulation to the defibrillating electrodes immediately following a compression cycle when the chest is allowed to expand.
3. The device of claim 1, further comprising:
at least one feedback device operably connected to the patient, wherein said feedback device comprises
a sensor,
an electrical signal generator and
a signal transmitter, and said feedback device senses at least one biological parameter of the patient, generates a corresponding electrical signal, and transmits the corresponding signal to the controller, and wherein the controller adjusts the operation of the electro-stimulation system on the basis of the sensed feedback.
4. The device of claim 2, wherein said feedback device further comprises:
a protection circuit for protecting the feedback device from electrical energy applied by the electro-stimulation system.
5. The device of claim 1, wherein the controller is capable of receiving a stop signal command to cease chest compression and electro-stimulation, and said controller checks for the stop signal command before each cycle of chest compression and before each application of electro-stimulation.
US12/392,018 1998-06-19 2009-02-24 Chest Compression Device with Electro-Stimulation Abandoned US20090177127A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/392,018 US20090177127A1 (en) 1998-06-19 2009-02-24 Chest Compression Device with Electro-Stimulation

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/100,840 US6213960B1 (en) 1998-06-19 1998-06-19 Chest compression device with electro-stimulation
US09/829,859 US20010018562A1 (en) 1998-06-19 2001-04-09 Chest compression device with electro-stimulation
US10/648,007 US7011637B2 (en) 1998-06-19 2003-08-25 Chest compression device with electro-stimulation
US11/374,855 US7497837B2 (en) 1998-06-19 2006-03-13 Chest compression device with electro-stimulation
US12/392,018 US20090177127A1 (en) 1998-06-19 2009-02-24 Chest Compression Device with Electro-Stimulation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/374,855 Continuation US7497837B2 (en) 1998-06-19 2006-03-13 Chest compression device with electro-stimulation

Publications (1)

Publication Number Publication Date
US20090177127A1 true US20090177127A1 (en) 2009-07-09

Family

ID=22281811

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/100,840 Expired - Lifetime US6213960B1 (en) 1998-06-19 1998-06-19 Chest compression device with electro-stimulation
US09/829,859 Abandoned US20010018562A1 (en) 1998-06-19 2001-04-09 Chest compression device with electro-stimulation
US10/648,007 Expired - Fee Related US7011637B2 (en) 1998-06-19 2003-08-25 Chest compression device with electro-stimulation
US11/374,855 Expired - Fee Related US7497837B2 (en) 1998-06-19 2006-03-13 Chest compression device with electro-stimulation
US12/392,018 Abandoned US20090177127A1 (en) 1998-06-19 2009-02-24 Chest Compression Device with Electro-Stimulation

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US09/100,840 Expired - Lifetime US6213960B1 (en) 1998-06-19 1998-06-19 Chest compression device with electro-stimulation
US09/829,859 Abandoned US20010018562A1 (en) 1998-06-19 2001-04-09 Chest compression device with electro-stimulation
US10/648,007 Expired - Fee Related US7011637B2 (en) 1998-06-19 2003-08-25 Chest compression device with electro-stimulation
US11/374,855 Expired - Fee Related US7497837B2 (en) 1998-06-19 2006-03-13 Chest compression device with electro-stimulation

Country Status (3)

Country Link
US (5) US6213960B1 (en)
AU (1) AU4677999A (en)
WO (1) WO1999065560A2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060142809A1 (en) * 2004-11-24 2006-06-29 Kai Kroll Medium voltage therapy applications in treating cardiac arrest
WO2012045176A1 (en) 2010-10-04 2012-04-12 Chu Sainte-Justine Biomechanical-based methods of diagnosing scoliosis
WO2013086421A1 (en) * 2011-12-07 2013-06-13 Med-El Elektromedizinische Geraete Gmbh Pacemaker for spasmodic dysphonia
US8483822B1 (en) 2009-07-02 2013-07-09 Galvani, Ltd. Adaptive medium voltage therapy for cardiac arrhythmias
US20150142084A1 (en) * 2009-11-18 2015-05-21 Case Western Reserve University Hybrid method for modulating upper airway function in a subject
US9345885B2 (en) 2011-12-07 2016-05-24 Med-El Elektromedizinische Geraete Gmbh Pacemaker for unilateral vocal cord autoparalysis
US9421391B2 (en) 2012-12-12 2016-08-23 Galvani, Ltd. Coordinated medium voltage therapy for improving effectiveness of defibrillation therapy
WO2016142937A1 (en) * 2015-03-09 2016-09-15 Mor Research Applications Ltd. Dynamically controllable apparatus for assisting cardio-pulmonary resuscitation
US9731131B2 (en) 2011-12-07 2017-08-15 Med-El Elektromedizinische Geraete Gmbh Pacemaker for unilateral vocal cord autoparalysis
WO2018083634A1 (en) * 2016-11-02 2018-05-11 Medsimlab Lda Thoracic device with non-invasive sensors for medical monitoring and clinical feedback of vital signs
WO2024144453A1 (en) * 2022-12-30 2024-07-04 Agency For Science, Technology And Research System and method for diaphragm stimulation during cpr

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6185457B1 (en) * 1994-05-31 2001-02-06 Galvani, Ltd. Method and apparatus for electrically forcing cardiac output in an arrhythmia patient
US6853859B1 (en) * 1994-05-31 2005-02-08 Galvani, Ltd. Electrical cardiac output forcer
US6213960B1 (en) * 1998-06-19 2001-04-10 Revivant Corporation Chest compression device with electro-stimulation
SE9802335D0 (en) * 1998-06-30 1998-06-30 Siemens Elema Ab Breathing Help System
US6125299A (en) * 1998-10-29 2000-09-26 Survivalink Corporation AED with force sensor
US9248306B2 (en) 1999-09-30 2016-02-02 Physio-Control, Inc. Pulse detection apparatus, software, and methods using patient physiological signals
US20060064131A1 (en) * 2000-02-04 2006-03-23 Freeman Gary A User interface for defibrillator for use by persons with limited training and experience
US20050131465A1 (en) 2000-02-04 2005-06-16 Freeman Gary A. Integrated resuscitation
EP1251908B1 (en) * 2000-02-04 2017-04-05 Zoll Medical Corporation Integrated resuscitation
EP1324709B1 (en) * 2000-09-26 2006-07-12 Medtronic, Inc. Medical device for directing blood flow
US6616620B2 (en) * 2001-05-25 2003-09-09 Revivant Corporation CPR assist device with pressure bladder feedback
US6870210B2 (en) * 2002-08-22 2005-03-22 Micron Technology, Inc. Dual-sided capacitor
US7569021B2 (en) * 2002-03-21 2009-08-04 Jolife Ab Rigid support structure on two legs for CPR
TW528593B (en) * 2002-05-17 2003-04-21 Jang-Min Yang Device for monitoring physiological status and method for using the device
US6827695B2 (en) 2002-10-25 2004-12-07 Revivant Corporation Method of determining depth of compressions during cardio-pulmonary resuscitation
US7277757B2 (en) * 2002-10-31 2007-10-02 Medtronic, Inc. Respiratory nerve stimulation
US20040138713A1 (en) * 2002-11-13 2004-07-15 Stickney Ronald E. External defibrillation and transcutaneous pacing device and methods for operating the device
US7308304B2 (en) * 2003-02-14 2007-12-11 Medtronic Physio-Control Corp. Cooperating defibrillators and external chest compression devices
US20040162510A1 (en) * 2003-02-14 2004-08-19 Medtronic Physio-Control Corp Integrated external chest compression and defibrillation devices and methods of operation
US20050038475A1 (en) * 2003-02-18 2005-02-17 Medtronic Physio-Control Corp. Defibrillators learning of other concurrent therapy
US7226427B2 (en) * 2003-05-12 2007-06-05 Jolife Ab Systems and procedures for treating cardiac arrest
US7840270B2 (en) * 2003-07-23 2010-11-23 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US20050107833A1 (en) * 2003-11-13 2005-05-19 Freeman Gary A. Multi-path transthoracic defibrillation and cardioversion
US7734344B2 (en) * 2003-12-02 2010-06-08 Uab Research Foundation Methods, systems and computer program products to inhibit ventricular fibrillation during cardiopulmonary resuscitation
US8805491B2 (en) * 2004-04-20 2014-08-12 Zoll Medical Corporation Microperfusive electrical stimulation
US7537575B2 (en) * 2004-04-22 2009-05-26 Electromed, Inc. Body pulsating method and apparatus
JP2006023707A (en) * 2004-06-08 2006-01-26 Canon Inc Transfer medium carrying member, intermediate transfer member, and image forming apparatus using same
US9259543B2 (en) 2004-10-25 2016-02-16 Zoll Medical Corporation Non-invasive device for synchronizing chest compression and ventilation parameters to residual myocardial activity during cardiopulmonary resuscitation
US7645247B2 (en) * 2004-10-25 2010-01-12 Norman A. Paradis Non-invasive device for synchronizing chest compression and ventilation parameters to residual myocardial activity during cardiopulmonary resuscitation
US20060155336A1 (en) * 2005-01-13 2006-07-13 Heath Roger L Medical resuscitation system and patient information module
US7720535B2 (en) * 2005-08-23 2010-05-18 Cardiac Pacemakers, Inc. Pacing management during cardiopulmonary resuscitation
US20070044669A1 (en) * 2005-08-24 2007-03-01 Geise Gregory D Aluminum can compacting mechanism with improved actuation handle assembly
US9050005B2 (en) * 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US7650181B2 (en) * 2005-09-14 2010-01-19 Zoll Medical Corporation Synchronization of repetitive therapeutic interventions
US7899556B2 (en) 2005-11-16 2011-03-01 Bioness Neuromodulation Ltd. Orthosis for a gait modulation system
US8209022B2 (en) 2005-11-16 2012-06-26 Bioness Neuromodulation Ltd. Gait modulation system and method
US8972017B2 (en) 2005-11-16 2015-03-03 Bioness Neuromodulation Ltd. Gait modulation system and method
US20070150023A1 (en) * 2005-12-02 2007-06-28 Ignagni Anthony R Transvisceral neurostimulation mapping device and method
US8105249B2 (en) * 2006-02-16 2012-01-31 Zoll Medical Corporation Synchronizing chest compression and ventilation in cardiac resuscitation
US8676323B2 (en) * 2006-03-09 2014-03-18 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
CA2652098A1 (en) * 2006-06-12 2007-12-21 Bioness Development, Llc Apparatus and method for positioning electrodes on the body
US8103341B2 (en) 2006-08-25 2012-01-24 Cardiac Pacemakers, Inc. System for abating neural stimulation side effects
US8002720B2 (en) * 2006-10-20 2011-08-23 Laerdal Medical As Support for chest compression system
AU2007229409A1 (en) 2006-10-20 2008-05-08 Laerdal Medical As Resuscitation system
US20080097534A1 (en) * 2006-10-20 2008-04-24 Helge Myklebust Resuscitation system
US7775996B2 (en) * 2006-10-20 2010-08-17 Laerdal Medical As Chest compression system
TWI360416B (en) * 2006-12-14 2012-03-21 Ind Tech Res Inst Apparatus of cardiopulmonary resuscitator
CA3000408C (en) 2007-01-29 2024-04-02 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
WO2008098001A2 (en) 2007-02-05 2008-08-14 Synapse Biomedical, Inc. Removable intramuscular electrode
DE102007014136B4 (en) * 2007-03-23 2011-08-25 Dr. Oestreich + Partner GmbH, 50670 Device for medical care of a patient in an emergency
WO2008144578A1 (en) 2007-05-17 2008-11-27 Synapse Biomedical, Inc. Devices and methods for assessing motor point electromyogram as a biomarker
US8696543B2 (en) * 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
SI2211768T1 (en) * 2007-10-11 2021-11-30 Implantica Patent Ltd. Apparatus for controlling flow in a bodily organ
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
WO2009059033A1 (en) 2007-10-30 2009-05-07 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
CN101568320B (en) * 2007-11-01 2013-09-11 Zoll医疗公司 Synchronization of defibrillation and chest compressions
US8511308B2 (en) * 2007-12-06 2013-08-20 Cpair, Inc. CPR system with feed back instruction
US8845589B2 (en) * 2008-01-18 2014-09-30 Thomas Clyde Hatch Device and methods for delivering fluids to animals
US20090187161A1 (en) * 2008-01-18 2009-07-23 Thomas Clyde Hatch Sheath and stomach tube
US20110178541A1 (en) * 2008-09-12 2011-07-21 Slender Medical, Ltd. Virtual ultrasonic scissors
DE202008014773U1 (en) * 2008-11-06 2009-01-15 Metrax Gmbh Emergency treatment device
WO2010071919A1 (en) * 2008-12-22 2010-07-01 The University Of Sydney Respiratory aid device
US12064391B2 (en) 2010-02-12 2024-08-20 Zoll Medical Corporation Defibrillator display including CPR depth information
US8725253B2 (en) 2010-02-12 2014-05-13 Zoll Medical Corporation Defibrillator display including CPR depth information
EP3978069A1 (en) * 2010-02-12 2022-04-06 Zoll Medical Corporation Defibrillator charging
US8880166B2 (en) 2010-02-12 2014-11-04 Zoll Medical Corporation Defibrillator display
US9198826B2 (en) 2010-07-13 2015-12-01 Physio-Control, Inc. CPR chest compression machine stopping to detect patient recovery
ES2385146B1 (en) * 2010-12-24 2013-06-11 Salvador Mercé Vives DEVICE FOR CARDIAC EMERGENCY ASSISTANCE.
US9095417B2 (en) 2011-02-07 2015-08-04 Bioness Neuromodulation Ltd. Adjustable orthosis for electrical stimulation of a limb
US8535251B1 (en) 2011-04-04 2013-09-17 Subhakar Patthi Rao Mechanical device to assist in the external compression of the chest during cardio-pulmonary resuscitation
CN103857371A (en) 2011-04-08 2014-06-11 Zoll医疗公司 Coordinated resuscitation perfusion support
US10238574B2 (en) 2011-04-08 2019-03-26 Zoll Medical Corporation System for assisting rescuers in performing cardio-pulmonary resuscitation (CPR) on a patient
US8868217B2 (en) 2011-06-27 2014-10-21 Bioness Neuromodulation Ltd. Electrode for muscle stimulation
US20140236055A1 (en) * 2011-11-08 2014-08-21 Koninklijke Philips N.V. Resuscitation device
EP2822645B1 (en) 2012-03-05 2017-05-03 Simon Fraser University Transvascular nerve stimulation apparatus
US8942800B2 (en) 2012-04-20 2015-01-27 Cardiac Science Corporation Corrective prompting system for appropriate chest compressions
EP2854743A4 (en) * 2012-06-01 2016-02-17 Zoll Medical Corp Chest compression belt with belt position monitoring system
JP2015524738A (en) * 2012-08-17 2015-08-27 ゾール メディカル コーポレイションZOLL Medical Corporation Heterologous chest compressions and ventilation
WO2014075915A1 (en) * 2012-11-13 2014-05-22 Schiller Ag Apparatus for providing cardiopulmonary resuscitation and application aid
US20140323928A1 (en) 2013-04-30 2014-10-30 Zoll Medical Corporation Compression Depth Monitor with Variable Release Velocity Feedback
EP2863987B1 (en) 2013-06-21 2023-08-02 Lungpacer Medical Inc. Transvascular diaphragm pacing systems
US8942803B1 (en) 2013-08-30 2015-01-27 Zoll Medical Corporation System and method for distinguishing manual from automated CPR
US20150088016A1 (en) 2013-09-25 2015-03-26 Zoll Medical Corporation Mobile Device Control
JP6456382B2 (en) 2013-11-22 2019-01-23 ラングペーサー メディカル インコーポレイテッドLungpacer Medical Inc. catheter
US9901510B2 (en) 2013-12-09 2018-02-27 Brett Gene Smith Portable apparatus for providing chest therapy
US10959912B2 (en) 2013-12-09 2021-03-30 Exemplar Medical LLC Portable apparatus for providing chest therapy
US12076483B2 (en) 2013-12-09 2024-09-03 Exemplar Medical LLC Portable apparatus for providing chest therapy
EP3824949B1 (en) 2014-01-21 2023-12-20 Lungpacer Medical Inc. Systems for optimization of multi-electrode nerve pacing
US10695264B2 (en) * 2014-05-07 2020-06-30 Jolife Ab CPR chest compression system with rate-based patient tranquility mode
US11246796B2 (en) 2014-06-06 2022-02-15 Physio-Control, Inc. Adjustable piston
US10004662B2 (en) 2014-06-06 2018-06-26 Physio-Control, Inc. Adjustable piston
US10092464B2 (en) 2014-10-03 2018-10-09 Physio-Control, Inc. Medical device stabilization strap
WO2016183460A1 (en) 2015-05-13 2016-11-17 Hive Concepts, LLC Devices, systems, and methods for muscle recovery
US10772793B2 (en) 2015-06-12 2020-09-15 Norman A. Paradis Mechanical cardiopulmonary resuscitation combining circumferential constriction and anteroposterior compression of the chest
US10406345B2 (en) 2015-10-16 2019-09-10 Zoll Medical Corporation Dual sensor electrodes for providing enhanced resuscitation feedback
US10639234B2 (en) 2015-10-16 2020-05-05 Zoll Circulation, Inc. Automated chest compression device
US10682282B2 (en) 2015-10-16 2020-06-16 Zoll Circulation, Inc. Automated chest compression device
WO2017087754A2 (en) * 2015-11-18 2017-05-26 President And Fellows Of Harvard College Compositions and methods of mechanically inducing tissue regeneration
WO2017189132A1 (en) * 2016-04-25 2017-11-02 SloMo Technologies, LLC Reducing brain injury by limiting brain motion during sudden deceleration or acceleration of the head
US12041997B2 (en) 2016-04-25 2024-07-23 Preactive Technologies Inc. Reducing brain injury by limiting brain motion during sudden deceleration or acceleration of the head
US11179286B2 (en) 2016-10-21 2021-11-23 Zoll Medical Corporation Adaptive body positioning
EP3558451B1 (en) * 2016-12-23 2024-02-14 Icahn School of Medicine at Mount Sinai System for assessing laryngeal and vagus nerve integrity in patients under general anesthesia
US10945699B2 (en) * 2016-12-28 2021-03-16 Hill-Rom Services Pte Ltd. Respiratory sound analysis for lung health assessment
US10832594B2 (en) 2017-03-09 2020-11-10 Zoll Medical Corporation Automated detection of cardiopulmonary resuscitation chest compressions
US11311457B2 (en) 2017-03-09 2022-04-26 Zoll Medical Corporation Automated detection of cardiopulmonary resuscitation chest compressions
US11712399B2 (en) * 2017-04-05 2023-08-01 Stryker Corporation Chest compression machine systems and methods
US11246795B2 (en) 2017-04-20 2022-02-15 Zoll Circulation, Inc. Compression belt assembly for a chest compression device
US10874583B2 (en) 2017-04-20 2020-12-29 Zoll Circulation, Inc. Compression belt assembly for a chest compression device
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
JP7184370B2 (en) 2017-06-30 2022-12-06 ラングペーサー メディカル インコーポレイテッド Device for prevention, alleviation and/or treatment of cognitive impairment
US11179293B2 (en) 2017-07-28 2021-11-23 Stryker Corporation Patient support system with chest compression system and harness assembly with sensor system
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10940308B2 (en) 2017-08-04 2021-03-09 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
US20190175908A1 (en) 2017-12-11 2019-06-13 Lungpacer Medical Inc. Systems and methods for strengthening a respiratory muscle
US11058349B2 (en) * 2018-03-24 2021-07-13 Ovadia Sagiv Non-invasive handling of sleep apnea, snoring and emergency situations
US10905629B2 (en) 2018-03-30 2021-02-02 Zoll Circulation, Inc. CPR compression device with cooling system and battery removal detection
US11253713B2 (en) 2018-07-17 2022-02-22 Norman Alan Paradis Incorporation of the electrodes for defibrillation into the patient-facing components of automated cardiopulmonary resuscitation systems
WO2020097331A1 (en) 2018-11-08 2020-05-14 Lungpacer Medical Inc. Stimulation systems and related user interfaces
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation
WO2020232333A1 (en) 2019-05-16 2020-11-19 Lungpacer Medical Inc. Systems and methods for sensing and stimulation
EP3983057A4 (en) 2019-06-12 2023-07-12 Lungpacer Medical Inc. Circuitry for medical stimulation systems
EP4335488A1 (en) * 2022-09-09 2024-03-13 Paradis, Norman Alan A multimodal device and method to increase the efficacy of transthoracic cardioversion or cardiac pacing in patients with perfusing rhythms

Citations (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2071215A (en) * 1934-10-15 1937-02-16 Petersen Peter Artificial respiration apparatus
US2699163A (en) * 1950-06-26 1955-01-11 Carl-Gunnar D Engstrom Respirator
US2754817A (en) * 1955-06-10 1956-07-17 Steffen P Nemeth Exercising device
US2780222A (en) * 1953-12-18 1957-02-05 J J Monaghan Company Inc Respirators
US2853998A (en) * 1955-02-28 1958-09-30 John H Emerson Respirator casing and methods of producing the same
US2899955A (en) * 1959-08-18 Respirator belt
US3042024A (en) * 1959-06-26 1962-07-03 Emanuel S Mendelson Inflatable double-walled resuscitation garment
US3120228A (en) * 1960-11-07 1964-02-04 Harris A Thompson Respirator apparatus
US3368550A (en) * 1965-04-26 1968-02-13 Glascock Harry Respiratory cuirass
US3461860A (en) * 1967-04-17 1969-08-19 Michigan Instr Inc Pulmonary ventilation system and combination cardiac compressor and ventilation system
US3481327A (en) * 1967-03-06 1969-12-02 Lillian G Drennen Respiratory vest for emphysema patients
US3610233A (en) * 1961-04-26 1971-10-05 Michigan Instr Inc Massage apparatus
US3782371A (en) * 1971-06-07 1974-01-01 R Derouineau Resuscitation apparatus for simultaneous cardiac massage and artificial respiration
US4198963A (en) * 1978-10-19 1980-04-22 Michigan Instruments, Inc. Cardiopulmonary resuscitator, defibrillator and monitor
US4349015A (en) * 1980-11-14 1982-09-14 Physio-Control Corporation Manually-actuable CPR apparatus
US4397306A (en) * 1981-03-23 1983-08-09 The John Hopkins University Integrated system for cardiopulmonary resuscitation and circulation support
US4570615A (en) * 1980-03-03 1986-02-18 Michigan Instruments, Inc. Cardiopulmonary resuscitator massager pad
US4664098A (en) * 1983-06-02 1987-05-12 Coromed International Cardiopulmonary resuscitator
US4770164A (en) * 1980-10-16 1988-09-13 Lach Ralph D Resuscitation method and apparatus
US4827935A (en) * 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
US4880004A (en) * 1988-06-07 1989-11-14 Intermedics, Inc. Implantable cardiac stimulator with automatic gain control and bandpass filtering in feedback loop
US4907602A (en) * 1985-10-18 1990-03-13 The Mount Sinai School Of Medicine Of The City Of New York Device for controlling the glottic opening
US4915095A (en) * 1988-05-02 1990-04-10 Newton Chun Cardiac CPR mechanism
US4928674A (en) * 1988-11-21 1990-05-29 The Johns Hopkins University Cardiopulmonary resuscitation and assisted circulation system
US5014698A (en) * 1987-10-06 1991-05-14 Leonard Bloom Method of and system for monitoring and treating a malfunctioning heart
US5056505A (en) * 1987-05-01 1991-10-15 Regents Of The University Of Minnesota Chest compression apparatus
US5078134A (en) * 1988-04-25 1992-01-07 Lifecor, Inc. Portable device for sensing cardiac function and automatically delivering electrical therapy
US5098369A (en) * 1987-02-27 1992-03-24 Vascor, Inc. Biocompatible ventricular assist and arrhythmia control device including cardiac compression pad and compression assembly
US5184606A (en) * 1990-07-05 1993-02-09 George Csorba Device for cardiac massage
US5184620A (en) * 1991-12-26 1993-02-09 Marquette Electronics, Inc. Method of using a multiple electrode pad assembly
US5190036A (en) * 1991-02-28 1993-03-02 Linder Steven H Abdominal binder for effectuating cough stimulation
US5217010A (en) * 1991-05-28 1993-06-08 The Johns Hopkins University Ecg amplifier and cardiac pacemaker for use during magnetic resonance imaging
US5222478A (en) * 1988-11-21 1993-06-29 Scarberry Eugene N Apparatus for application of pressure to a human body
US5257619A (en) * 1992-10-07 1993-11-02 Everete Randall L External cardiac compression device
US5273114A (en) * 1992-06-05 1993-12-28 Shell Oil Company Gravel pack apparatus and method
US5277194A (en) * 1989-01-31 1994-01-11 Craig Hosterman Breathing monitor and stimulator
US5284135A (en) * 1992-02-21 1994-02-08 Zmd Corporation Electrical connection between transcutaneous pacing circuitry and defibrillation circuitry
US5295481A (en) * 1991-11-01 1994-03-22 Geeham Calvin T Cardiopulmonary resuscitation assist device
US5327887A (en) * 1993-01-25 1994-07-12 Ludwik Nowakowski Cardiopulmonary resuscitation device
US5359999A (en) * 1991-06-20 1994-11-01 Kinsman James B Asynchronous cycling of mechanical ventilators
US5370603A (en) * 1993-02-25 1994-12-06 The United States Of America As Represented By The Secretary Of The Air Force Pneumatic CPR garment
US5397337A (en) * 1992-04-02 1995-03-14 Illinois Institute Of Technology Method and apparatus for artificially stimulating cough reflex
US5399148A (en) * 1990-07-06 1995-03-21 Baswat Holdings Pty. Ltd. External cardiac massage device
US5405362A (en) * 1991-04-29 1995-04-11 The Board Of Regents For The University Of Texas System Interactive external defibrillation and drug injection system
US5411031A (en) * 1993-11-24 1995-05-02 Incontrol, Inc. Implantable cardiac patient monitor
US5474533A (en) * 1994-04-11 1995-12-12 The Ohio State University Intrathoracic mechanical, electrical and temperature adjunct to cardiopulmonary cerebral resuscitation, shock, head injury, hypothermia and hyperthermia
US5490820A (en) * 1993-03-12 1996-02-13 Datascope Investment Corp. Active compression/decompression cardiac assist/support device and method
US5630789A (en) * 1994-10-07 1997-05-20 Datascope Investment Corp. Active compression/decompression device for cardiopulmonary resuscitation
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5716380A (en) * 1996-04-15 1998-02-10 Physio-Control Corporation Common therapy/data port for a portable defibrillator
US5733869A (en) * 1995-10-06 1998-03-31 Baxter International, Inc. Therapeutic administration of hemoglobin in cardiac arrest
US5738637A (en) * 1995-12-15 1998-04-14 Deca-Medics, Inc. Chest compression apparatus for cardiac arrest
US5755756A (en) * 1995-09-15 1998-05-26 Freedman, Jr.; Robert J. Hypothermia-inducing resuscitation unit
US5814086A (en) * 1996-10-18 1998-09-29 Pacesetter Ab Perex respiratory system stimulation upon tachycardia detection
US5833711A (en) * 1996-04-01 1998-11-10 Cardi-Act, L.L.C. Method and means for portable emergency cardiopulmonary resuscitation
US6213960B1 (en) * 1998-06-19 2001-04-10 Revivant Corporation Chest compression device with electro-stimulation
US6234985B1 (en) * 1998-06-11 2001-05-22 Cprx Llc Device and method for performing cardiopulmonary resuscitation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273114A (en) 1978-10-19 1981-06-16 Michigan Instruments, Inc. Cardiopulmonary resuscitator, defibrillator and monitor
US4541417A (en) * 1982-06-07 1985-09-17 Krikorian Paul P Coronary augmenter
US5237887A (en) * 1991-07-01 1993-08-24 Rockwell International Corporation Straight line mechanism
US5806512A (en) * 1996-10-24 1998-09-15 Life Support Technologies, Inc. Cardiac/pulmonary resuscitation method and apparatus

Patent Citations (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899955A (en) * 1959-08-18 Respirator belt
US2071215A (en) * 1934-10-15 1937-02-16 Petersen Peter Artificial respiration apparatus
US2699163A (en) * 1950-06-26 1955-01-11 Carl-Gunnar D Engstrom Respirator
US2780222A (en) * 1953-12-18 1957-02-05 J J Monaghan Company Inc Respirators
US2853998A (en) * 1955-02-28 1958-09-30 John H Emerson Respirator casing and methods of producing the same
US2754817A (en) * 1955-06-10 1956-07-17 Steffen P Nemeth Exercising device
US3042024A (en) * 1959-06-26 1962-07-03 Emanuel S Mendelson Inflatable double-walled resuscitation garment
US3120228A (en) * 1960-11-07 1964-02-04 Harris A Thompson Respirator apparatus
US3610233A (en) * 1961-04-26 1971-10-05 Michigan Instr Inc Massage apparatus
US3368550A (en) * 1965-04-26 1968-02-13 Glascock Harry Respiratory cuirass
US3481327A (en) * 1967-03-06 1969-12-02 Lillian G Drennen Respiratory vest for emphysema patients
US3461860A (en) * 1967-04-17 1969-08-19 Michigan Instr Inc Pulmonary ventilation system and combination cardiac compressor and ventilation system
US3782371A (en) * 1971-06-07 1974-01-01 R Derouineau Resuscitation apparatus for simultaneous cardiac massage and artificial respiration
US4198963A (en) * 1978-10-19 1980-04-22 Michigan Instruments, Inc. Cardiopulmonary resuscitator, defibrillator and monitor
US4570615A (en) * 1980-03-03 1986-02-18 Michigan Instruments, Inc. Cardiopulmonary resuscitator massager pad
US4770164A (en) * 1980-10-16 1988-09-13 Lach Ralph D Resuscitation method and apparatus
US4349015A (en) * 1980-11-14 1982-09-14 Physio-Control Corporation Manually-actuable CPR apparatus
US4397306A (en) * 1981-03-23 1983-08-09 The John Hopkins University Integrated system for cardiopulmonary resuscitation and circulation support
US4664098A (en) * 1983-06-02 1987-05-12 Coromed International Cardiopulmonary resuscitator
US4907602A (en) * 1985-10-18 1990-03-13 The Mount Sinai School Of Medicine Of The City Of New York Device for controlling the glottic opening
US4827935A (en) * 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
US5098369A (en) * 1987-02-27 1992-03-24 Vascor, Inc. Biocompatible ventricular assist and arrhythmia control device including cardiac compression pad and compression assembly
US5056505A (en) * 1987-05-01 1991-10-15 Regents Of The University Of Minnesota Chest compression apparatus
US5014698A (en) * 1987-10-06 1991-05-14 Leonard Bloom Method of and system for monitoring and treating a malfunctioning heart
US5078134A (en) * 1988-04-25 1992-01-07 Lifecor, Inc. Portable device for sensing cardiac function and automatically delivering electrical therapy
US4915095A (en) * 1988-05-02 1990-04-10 Newton Chun Cardiac CPR mechanism
US4880004A (en) * 1988-06-07 1989-11-14 Intermedics, Inc. Implantable cardiac stimulator with automatic gain control and bandpass filtering in feedback loop
US4928674A (en) * 1988-11-21 1990-05-29 The Johns Hopkins University Cardiopulmonary resuscitation and assisted circulation system
US5222478A (en) * 1988-11-21 1993-06-29 Scarberry Eugene N Apparatus for application of pressure to a human body
US5277194A (en) * 1989-01-31 1994-01-11 Craig Hosterman Breathing monitor and stimulator
US5184606A (en) * 1990-07-05 1993-02-09 George Csorba Device for cardiac massage
US5399148A (en) * 1990-07-06 1995-03-21 Baswat Holdings Pty. Ltd. External cardiac massage device
US5190036A (en) * 1991-02-28 1993-03-02 Linder Steven H Abdominal binder for effectuating cough stimulation
US5405362A (en) * 1991-04-29 1995-04-11 The Board Of Regents For The University Of Texas System Interactive external defibrillation and drug injection system
US5217010A (en) * 1991-05-28 1993-06-08 The Johns Hopkins University Ecg amplifier and cardiac pacemaker for use during magnetic resonance imaging
US5359999A (en) * 1991-06-20 1994-11-01 Kinsman James B Asynchronous cycling of mechanical ventilators
US5295481A (en) * 1991-11-01 1994-03-22 Geeham Calvin T Cardiopulmonary resuscitation assist device
US5184620A (en) * 1991-12-26 1993-02-09 Marquette Electronics, Inc. Method of using a multiple electrode pad assembly
US5284135A (en) * 1992-02-21 1994-02-08 Zmd Corporation Electrical connection between transcutaneous pacing circuitry and defibrillation circuitry
US5397337A (en) * 1992-04-02 1995-03-14 Illinois Institute Of Technology Method and apparatus for artificially stimulating cough reflex
US5273114A (en) * 1992-06-05 1993-12-28 Shell Oil Company Gravel pack apparatus and method
US5257619A (en) * 1992-10-07 1993-11-02 Everete Randall L External cardiac compression device
US5327887A (en) * 1993-01-25 1994-07-12 Ludwik Nowakowski Cardiopulmonary resuscitation device
US5370603A (en) * 1993-02-25 1994-12-06 The United States Of America As Represented By The Secretary Of The Air Force Pneumatic CPR garment
US5490820A (en) * 1993-03-12 1996-02-13 Datascope Investment Corp. Active compression/decompression cardiac assist/support device and method
US5411031A (en) * 1993-11-24 1995-05-02 Incontrol, Inc. Implantable cardiac patient monitor
US5474533A (en) * 1994-04-11 1995-12-12 The Ohio State University Intrathoracic mechanical, electrical and temperature adjunct to cardiopulmonary cerebral resuscitation, shock, head injury, hypothermia and hyperthermia
US5630789A (en) * 1994-10-07 1997-05-20 Datascope Investment Corp. Active compression/decompression device for cardiopulmonary resuscitation
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5755756A (en) * 1995-09-15 1998-05-26 Freedman, Jr.; Robert J. Hypothermia-inducing resuscitation unit
US5733869A (en) * 1995-10-06 1998-03-31 Baxter International, Inc. Therapeutic administration of hemoglobin in cardiac arrest
US5738637A (en) * 1995-12-15 1998-04-14 Deca-Medics, Inc. Chest compression apparatus for cardiac arrest
US5833711A (en) * 1996-04-01 1998-11-10 Cardi-Act, L.L.C. Method and means for portable emergency cardiopulmonary resuscitation
US5716380A (en) * 1996-04-15 1998-02-10 Physio-Control Corporation Common therapy/data port for a portable defibrillator
US5814086A (en) * 1996-10-18 1998-09-29 Pacesetter Ab Perex respiratory system stimulation upon tachycardia detection
US6234985B1 (en) * 1998-06-11 2001-05-22 Cprx Llc Device and method for performing cardiopulmonary resuscitation
US6213960B1 (en) * 1998-06-19 2001-04-10 Revivant Corporation Chest compression device with electro-stimulation

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8401637B2 (en) 2004-11-24 2013-03-19 Galvani, Ltd. Medium voltage therapy applications in treating cardiac arrest
US20060142809A1 (en) * 2004-11-24 2006-06-29 Kai Kroll Medium voltage therapy applications in treating cardiac arrest
US9144684B2 (en) 2009-07-02 2015-09-29 Galvani, Ltd. Medium voltage therapy applied as a test of a physiologic state
US8483822B1 (en) 2009-07-02 2013-07-09 Galvani, Ltd. Adaptive medium voltage therapy for cardiac arrhythmias
US9517340B2 (en) * 2009-11-18 2016-12-13 Case Western Reserve University Hybrid method for modulating upper airway function in a subject
US20150142084A1 (en) * 2009-11-18 2015-05-21 Case Western Reserve University Hybrid method for modulating upper airway function in a subject
US10213600B2 (en) * 2009-11-18 2019-02-26 Case Western Reserve University Hybrid method for modulating upper airway function in a subject
US20170036018A1 (en) * 2009-11-18 2017-02-09 Case Western Reserve University Hybrid method for modulating upper airway function in a subject
US9029094B2 (en) 2010-10-04 2015-05-12 Chu Sainte-Justine Biomechanical-based methods of diagnosing scoliosis
WO2012045176A1 (en) 2010-10-04 2012-04-12 Chu Sainte-Justine Biomechanical-based methods of diagnosing scoliosis
US9731123B2 (en) 2011-12-07 2017-08-15 Med-El Elektromedizinische Geraete Gmbh Pacemaker for spasmodic dysphonia
US9345885B2 (en) 2011-12-07 2016-05-24 Med-El Elektromedizinische Geraete Gmbh Pacemaker for unilateral vocal cord autoparalysis
US9731131B2 (en) 2011-12-07 2017-08-15 Med-El Elektromedizinische Geraete Gmbh Pacemaker for unilateral vocal cord autoparalysis
WO2013086421A1 (en) * 2011-12-07 2013-06-13 Med-El Elektromedizinische Geraete Gmbh Pacemaker for spasmodic dysphonia
US9050462B2 (en) 2011-12-07 2015-06-09 Med-El Elektromedizinische Geraete Gmbh Pacemaker for spasmodic dysphonia
US9421391B2 (en) 2012-12-12 2016-08-23 Galvani, Ltd. Coordinated medium voltage therapy for improving effectiveness of defibrillation therapy
WO2016142937A1 (en) * 2015-03-09 2016-09-15 Mor Research Applications Ltd. Dynamically controllable apparatus for assisting cardio-pulmonary resuscitation
WO2018083634A1 (en) * 2016-11-02 2018-05-11 Medsimlab Lda Thoracic device with non-invasive sensors for medical monitoring and clinical feedback of vital signs
WO2024144453A1 (en) * 2022-12-30 2024-07-04 Agency For Science, Technology And Research System and method for diaphragm stimulation during cpr

Also Published As

Publication number Publication date
US20010018562A1 (en) 2001-08-30
US7011637B2 (en) 2006-03-14
US6213960B1 (en) 2001-04-10
WO1999065560A2 (en) 1999-12-23
AU4677999A (en) 2000-01-05
US20060155222A1 (en) 2006-07-13
WO1999065560A3 (en) 2000-04-06
US20040039313A1 (en) 2004-02-26
US7497837B2 (en) 2009-03-03

Similar Documents

Publication Publication Date Title
US7497837B2 (en) Chest compression device with electro-stimulation
US8700147B2 (en) Synchronization of defibrillation and chest compressions
US9839576B2 (en) Coordinated resuscitation perfusion support
US6224562B1 (en) Methods and devices for performing cardiopulmonary resuscitation
US7226427B2 (en) Systems and procedures for treating cardiac arrest
US6312399B1 (en) Stimulatory device and methods to enhance venous blood return during cardiopulmonary resuscitation
US7077814B2 (en) Resuscitation method using a sensed biological parameter
US7734344B2 (en) Methods, systems and computer program products to inhibit ventricular fibrillation during cardiopulmonary resuscitation
CA2732191C (en) Resuscitation device

Legal Events

Date Code Title Description
AS Assignment

Owner name: ZOLL CIRCULATION, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:REVIVANT CORPORATION;REEL/FRAME:022544/0565

Effective date: 20051103

Owner name: REVIVANT CORPORATION, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:EMERGENCY MEDICAL SYSTEMS, INC.;REEL/FRAME:022544/0506

Effective date: 20000630

Owner name: EMERGENCY MEDICAL SYSTEMS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHERMAN, DARREN R.;BYSTROM, STEVEN R.;REEL/FRAME:022544/0412

Effective date: 19980811

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION